Podcasts about ear infirmary

Hey, Doc! What's Wrong with My Eye?: A General Guide to Eye Symptoms by John C Barber https://www.amazon.com/Hey-Doc-Whats-Wrong-Eye/dp/1543429319 Johncbarber.com This book is a primer on eye disease. It is written for the nonphysician but would benefit physicians and paramedical personnel who are not eye physicians. Dr. Barber explains the common signs and symptoms of eye diseases and explains the usual treatments for these diseases, including glaucoma, cataracts, macular degeneration, and strabismus. It contains chapters about the ways diabetes, thyroid disease, AIDS, and other systemic diseases affect the eye. Several chapters explain the surgery for correction of cataracts, retinal detachment, crooked eyes, and glaucoma. There is a section on eye diseases of childhood. This book is recommended for employees in ophthalmic offices to better understand patient problems and the doctor's treatments.Author John C. Barber, MD, author of several books related to the practice of medicine. DR. BARBER spent a career in academic ophthalmology. During his fellowship in corneal diseases at Massachusetts Eye and Ear Infirmary in Boston, he began working with corneal prostheses. He has conducted research on collagenase inhibition, serum anti-proteases in the cornea and the development of an effective corneal prosthesis. These fields have all come together in this book which describes the development of a keratoprosthesis. He has implanted more than sixty prostheses in cat eyes. He is a charter member of the Keratoprosthesis Study Group and has attended meetings of the group in the United States and Europe. Dr. Barber has published over seventy articles and abstracts in scientific journals including several concerning the development of keratoprostheses. During eighteen years at the University of Texas Medical Branch, nine as Chairman of the Department of Ophthalmology, and twelve years as chairman at the St. Francis Medical Center he saw many patients who needed a keratoprosthesis for diseases including Ocular Cicatricial Pemphigoid, Stevens Johnson Syndrome, alkali burns, severe dry eyes, and amoebic keratitis. He ran residency programs at both institutions and trained over ninety ophthalmologists.

Vidcast:  https://www.instagram.com/p/DQdnYr9jZwV/An exciting, ground-breaking clinical study now shows that children born with a defective gene coding for a vital inner ear protein can have that gene  repaired and hearing restored. This phenomenally successful preliminary clinical trial was recently published in the New England Journal of Medicine.Genetic bioengineers at New York's Regeneron Pharmaceuticals loaded a normal copy of the otoferlin gene into a dual adeno-associated virus acting as a Trojan horse.  Twelve children, born without the ability to synthesize otoferlin protein, received the gene injection, dubbed DB-OTO therapy, into their inner ears at 3 clinical centers: Harvard's Mass. Eye and Ear Infirmary, UC San Diego's Children's Hospital, and University College London.  Otoferlin is necessary for the inner ear's ability to convert sound vibrations into electrical impulses.  At 24 weeks post-injection, 9 of the 12 children, 75%, regained measurable hearing.  Three, 25%, developed near normal hearing.  The gene therapy was well-tolerated without any significant side effects.This gene therapy, with further refinement and after larger clinical trials, may be a one-and-done treatment for one common form of congenital deafness. Cochlear implants will continue to be essential therapy for other types of genetic and acquired severe hearing losses pending development of other genetic and/or chemical cochlear modifications.https://www.nejm.org/doi/full/10.1056/NEJMoa2400521#deafness #children #congenital #otoferlin #dboto 

Introduction In Episode 17 of the Eye -Q Podcast, host Dr. Rudrani Banik delves into one of the most pervasive—and often underrecognized, ocular surface challenges: dry eye. Joining the conversation is Dr. Masako Chen, board-certified cornea surgeon at the New York Eye and Ear Infirmary of Mount Sinai and Associate Residency Program Director, whose expertise […]

Vidcast:  https://www.instagram.com/reel/DH9UqL2spnA/Cells taken from the edge of a healthy cornea can become a magic bullet to repair a previously considered irreparable cornea in the opposite eye.  Ophthalmologists at Harvard's Mass. Eye and Ear Infirmary developed what they term the CALEC procedure, an acronym for Cultivated Autologous Limbal Epithelial Cells.  The limbal region of the cornea contains stem cells that constantly renew the corneal surface.  These cells are harvested and grown out into a tissue graft in a laboratory at Boston's Dana-Farber Cancer Institute.  The graft is then implanted in the diseased eye.The researchers report their preliminary trial of 14 patients in the journal Nature Communications.  The procedure boasts a 93% success rate for significant corneal repair with 79% of the subjects enjoying complete restoration of their injured corneas by 1 year postoperatively.After additional trials are complete, this procedure will be ready to restore sight in eyes once considered hopelessly blinded…. Someday soon.https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/calec-stem-cell-therapy-clinical-trial-repairs-corneal-damage#cornea #stemcells #limbus #calec 

Welcome to the Personal Development Trailblazers Podcast! In today's episode, we'll break down the science of decision-making to help you escape burnout and design a career you loveMark Shrime is an internationally renowned speaker, surgeon, author, coach, and cat dad. He serves as the Editor-in-Chief of BMJ Global Health and a Lecturer in Global Health and Social Medicine at Harvard Medical School.Previously, he was the International Chief Medical Officer at Mercy Ships, the founding O'Brien Chair of Global Surgery at the Royal College of Surgeons in Ireland, and the Director of the Center for Global Surgery Evaluation at Massachusetts Eye and Ear Infirmary. He also served as Research Director for the Program in Global Surgery and Social Change at Harvard. Trained in otolaryngology, head and neck surgery, and microvascular reconstructive surgery, he earned an MPH in global health (2011) and a PhD in Health Policy focused on decision-making (2015).Clinically, he specializes in large head and neck tumors with Mercy Ships, working closely with residents from the Pan-African Academy of Christian Surgeons. He has worked and taught in multiple countries, including Liberia, Sierra Leone, Guinea, Benin, and Madagascar. His research explores the global burden of surgical disease, financial barriers to care, and surgical access worldwide. As a co-author of the Lancet Commission on Global Surgery, he focuses on optimizing surgical policies to improve health outcomes while reducing financial hardship for patients.Beyond surgery, his coaching, writing, and speaking help people navigate major life decisions. He merges personal experience with decision science to guide others in building a life of purpose and fulfillment. His book, Solving for Why, has sold nearly 15,000 copies. Outside of his professional endeavors, he is a photographer, rock climber, and ninja warrior. He competed on Seasons 8, 9, and 11 of American Ninja Warrior.Connect with Mark Here: Instagram / Threads: @markshrimeLinkedIn: https://www.linkedin.com/in/markshrime/Medium: @shrimePersonal website: markshrime.comWebsite: solvingforwhy.coGrab the freebie here: markshrime.com/anatomy-pdf===================================If you enjoyed this episode, remember to hit the like button and subscribe. Then share this episode with your friends.Thanks for watching the Personal Development Trailblazers Podcast. This podcast is part of the Digital Trailblazer family of podcasts. To learn more about Digital Trailblazer and what we do to help entrepreneurs, go to DigitalTrailblazer.com.Are you a coach, consultant, expert, or online course creator? Then we'd love to invite you to our FREE Facebook Group where you can learn the best strategies to land more high-ticket clients and customers. QUICK LINKS: APPLY TO BE FEATURED: https://app.digitaltrailblazer.com/podcast-guest-applicationDIGITAL TRAILBLAZER: https://digitaltrailblazer.com/

Liz is joined by Dr. Varun Malhotra on the podcast this month to discuss clinical competency exams for clinical support reps. As both a practicing physician and an industry leader, he shares invaluable perspective on both how a rep should act in the OR and how companies should prepare reps to do so. In 2025, we're embarking on a MedDevice Training Journey: From clinical trials to standard of care. Join us all year long as we explore training at each stage of the product life cycle.Related Resources:Dr. Varun Malhotra is an ophthalmologist with specialized training in glaucoma who has successfully bridged the worlds of clinical practice and biotechnology innovation.Dr. Malhotra completed his undergraduate education at Dartmouth College before earning his medical degree from New York University School of Medicine. He continued at NYU for his ophthalmology residency, gaining comprehensive training in diagnosing and treating various eye conditions. His education was further enhanced with a specialized fellowship in glaucoma at the prestigious Illinois Eye and Ear Infirmary, where he developed expertise in managing this complex eye disease.With additional credentials including an MBA from the University of Chicago Booth School of Business, Dr. Malhotra cultivated a multifaceted career spanning both academic and private practice settings before making a strategic transition to the biotechnology sector with a role at Genentech, where he was the clinical lead for the Port Delivery System Diabetic Macular Edema program. He also served as the global surgical lead for the entire Port Delivery System, where he oversaw the expansion and surgical training for all internal and external stakeholders of ophthalmic clinical trials from the United States to encompass countries in Europe, South America, and Asia.Dr. Malhotra is currently the Vice President of Clinical Development for Ollin Bioscience, an ophthalmic biotech company. He still practices ophthalmology and trains resident physicians in clinical and surgical skills on a weekly basis. Subscribe to our newsletter to hear more about the journey from clinical trials to standard of care! Click here to subscribe!Connect with us on LinkedIn:   ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Varun MalhotraCumby Consulting⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Rachel Medeiros⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Liz Cumby⁠⁠⁠⁠⁠About Cumby Consulting:   Cumby Consulting's team of professionals deliver innovative MedTech training services for physicians, sales representatives, teaching faculty, key opinion leaders and clinical development teams. Whether you need a complete training system developed to deliver revenue sooner or a discrete training program for a specific meeting, Cumby Consulting will deliver highly strategic, efficient programs with uncompromising standards of quality."

Vidcast:  Vidcast: https://www.instagram.com/p/DF_Do23geGi/The pattern of blood vessels at the back of your eyes, in your retinas, could be an early warning sign that your risk of stroke may be up to 20% higher than normal.  So say research ophthalmologists at Australia's Royal Victorian Eye and Ear Hospital working with colleagues at Harvard's Mass.Eye and Ear Infirmary.The eye's retina is the only part of the body offering a direct view of your blood vessels.  Observing vascular patterns in the eyes of some 45,161 subjects followed over 12.5 years, the investigators discovered 29 indicators linked to increased stroke risk.  Significant changes in these indicators predicted an increased risk of stroke from 9.8 to 19%.This retinal vascular analysis appears to more predictive of strokes than more conventional non-invasive methods.  With further refinement, it can only improve.https://heart.bmj.com/content/early/2025/01/03/heartjnl-2024-324705#retina #stroke #screeing #noninvasive #australia #boston

Rudrani Banik, MD, IFMCP, joins Integrative Practitioner Content Specialist Avery St. Onge to discuss the most common age-related eye conditions and how they can be prevented with specific nutrients that target the various structure of the eye. This episode is brought to you by the Integrative Healthcare Symposium. Register for the Symposium and receive 15% off with promo code IP2025PODCAST: https://xpressreg.net/register/ihsy0225/landing.php?sc=IP2025PODCAST Learn more about the event by visiting the Symposium website: www.ihsymposium.com Contact the Integrative Healthcare Symposium team: info@ihsymposium.com Find us at integrativepractitioner.com or e-mail us at IPEditor@divcom.com. Theme music: "Upbeat Party" by Scott Holmes via freemusicarchive.org, "Carefree" by Kevin Mcleod via incompetech.com, and “Relaxing Light Background” by AudioCoffee. About the Expert Rudrani Banik, MD, IFMCP, is a board-certified ophthalmologist and fellowship-trained neuro-ophthalmologist with additional training in Functional Medicine. She completed her BA/MD as part of the prestigious combined eight-year Program in Liberal Medical Education at Brown University in Rhode Island. Dr. Banik then did her internship at Mount Sinai Medical Center in Miami, followed by Ophthalmology Residency at University of California, Irvine. She then completed a Neuro-Ophthalmology Fellowship under Dr. Neil Miller at Wilmer Eye Institute/Johns Hopkins. She maintains an academic appointment at New York Eye and Ear Infirmary of Mount Sinai as Associate Professor of Ophthalmology, where she actively teaches and supervises residents, fellows, and medical students. She also serves as Principal Investigator for the clinical trials in Neuro-Ophthalmology. She has published over 40 peer-reviewed articles and has been a speaker at both national and international meetings. Dr. Banik is a fellow of the American Academy of Ophthalmology (AAO) and the North American Neuro-Ophthalmology Society (NANOS). She also serves on the American Board of Ophthalmology's Exam Development Committee, a role she enjoys through which she helps maintain the standards of board certification in ophthalmology.

In this special throwback episode, John Hovanesian, MD, and Jim Mazzo revisit their discussions with Steven Schwartz, MD, and Sean Ianculev, MD, about innovations, treatments and entrepreneurship in eye care. Welcome to the Eyeluminaries podcast :10 About Steven Schwartz, MD 2:32 The interview 3:16 Discussion of current innovation in cataract surgery including use of AI, imaging and robotics 4:05 Discussion on Schwartz's involvement in Neurotech MacTel cell-based treatment 6:32 Advances and disappointments in retinal disease treatments? 10:32 How do companies come back from disappointing trial results? 11:07 Why do retina discoveries take so long to develop? 14:31 New dry AMD treatments in development? 15:58  Drug delivery technologies and will retina specialists use them? What do you predict we'll be doing differently in medicine 2 years from now and why? 22:00 What's the difference between a retina and cornea specialist? 23:52 Introduction of Sean Ianchulev, MD, MPH 25:38 The interview 26:29 Impact on Google Glass 30:27 What innovations are you proud of and what projects are you excited about? 35:31 What advice do you have for new entrepreneurs? 42:16 How do you balance your work life and your home life? 45:25 Legends in the field of ophthalmology 47:39 Give feedback at eyeluminaries@healio.com 49:36 Thanks for listening 49:57 Sean Ianchulev, MD, MPH, is a Harvard-trained physician-scientist, a professor of ophthalmology and the head of innovation and technology at New York Eye and Ear Infirmary founder and chairman of Iantrek Inc and Eyenovia and serves as a board member for the American Society of Cataract and Refractive Surgery Foundation and AEYE Health. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo sits on numerous ophthalmic industry corporate boards and committees after serving in executive roles with Allergan, Avellino Labs, Carl Zeiss and AMO. Steven Schwartz, MD, is the Ahmanson professor in ophthalmology and the chief of the retina division at the UCLA Jules Stein Eye Institute and the director of the Diabetic Eye Disease and Retinal Vascular Center. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. You can reach Dr. Schwartz via email at schwartzpatients@jsei.ucla.edu. You can find Dr. Ianchulev on LinkedIn.  Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Schwartz is the co-founder of Horizon Surgical; member on the National Eye Institute Audacious Initiative Scientific executive committee and reports receiving grants from Neurotech, Optos/Nikon, the California Institute of Regenerative Medicine; and investigator fees from Neurotech and Optos/Nikon and the California Institute of Regenerative Medicine.

Send us a Text Message.He arrived in Chicago from Boston in the mid-1800s and set up an Eye and Ear Infirmary to help those in need. Hear the story of Dr. Edward Lorenzo Holmes and his efforts to help the less fortunate in Chicago.West Loop: Then and Now by Connie FairbanksBuy it from the author: https://www.conniefairbanks.com/shop-1Show your support of the show for the cost of a coffee:https://www.buymeacoffee.com/chicagohistoryLeave me a voice message - just click on the microphone in the lower right corner here: https://www.chicagohistorypod.comUp your cocktail or Sodastream game with Portland craft syrups!https://portlandsyrups.com/collections/all?sca_ref=1270971.MO4APpJH1kAffiliate Links (anything you buy  through these links - not just this stuff - helps benefit the show at no additional cost to you):BOOKS:Chicago's West Loop: Then and Now by Connie Fairbankshttps://amzn.to/46U00J7 (Kindle Edition)Chicago Portraits: New Edition by June Skinner Sawyershttps://amzn.to/3WRoTQWChicago's Parks: A Photographic History by John Grafhttps://amzn.to/43Hod3x (Paperback)https://amzn.to/3Tz8Khv (FREE with Kindle Unlimited)Want to read hundreds of books for FREE every month? Try Kindle Unlimited: https://amzn.to/4dInhRbChicago History Podcast Art by John K. Schneider (angeleyesartjks  AT gmail.com)Gear used in the recording of this podcast:Shure MV7 Microphone: https://amzn.to/4aN8Xo6Zoom H6 Recorder: https://amzn.to/3y0wWh0Support the Show.

Welcome to an interview with the author of Solving for Why: A Surgeon's Journey to Discover the Transformative Power of Purpose, Dr. Mark G. Shrime. Solving for Why is an inspiring memoir about finding the answer to life's biggest question—"Why?"—and about following that answer through remarkable, unlikely places on the road to fulfillment, purpose, and joy.   "Turning your heart toward the poor doesn't have to be on a hospital ship in West Africa. It doesn't have to be grandiose. It doesn't have to be newsworthy. It doesn't have to be what your friends, pastors, rabbis, priests, or colleagues say it should. It just has to be." Dr. Mark Shrime   Dr. Mark G. Shrime is the International Chief Medical Officer at Mercy Ships and a Lecturer in Global Health and Social Medicine at the Harvard Medical School. He is the author of Solving for Why: A Surgeon's Journey to Discover the Transformative Power of Purpose (Hachette 2022).   He previously served as the O'Brien Chair of Global Surgery at the Royal College of Surgeons in Ireland, as the founder and Director of the Center for Global Surgery Evaluation at the Massachusetts Eye and Ear Infirmary, and as Research Director for the Program in Global Surgery and Social Change at Harvard.    He has spoken at the United Nations, WHO, Harvard, Princeton, and around the world addressing issues of healthcare inequity, moral injury in the healthcare workforce, and the non-health outcomes of health policies. In 2018, he was awarded the Arnold P. Gold Humanism in Medicine Award by the American Academy of Otolaryngology—Head and Neck Surgery.   Get Solving for Why here: https://rb.gy/okpa08   Here are some free gifts for you: Overall Approach Used in Well-Managed Strategy Studies free download: www.firmsconsulting.com/OverallApproach   McKinsey & BCG winning resume free download: www.firmsconsulting.com/resumepdf   Enjoying this episode? Get access to sample advanced training episodes here: www.firmsconsulting.com/promo

Welcome to Strategy Skills episode 457, featuring an interview with the author of Solving for Why: A Surgeon's Journey to Discover the Transformative Power of Purpose, Dr. Mark G. Shrime. Solving for Why is an inspiring memoir about finding the answer to life's biggest question—"Why?"—and about following that answer through remarkable, unlikely places on the road to fulfillment, purpose, and joy.   "Turning your heart toward the poor doesn't have to be on a hospital ship in West Africa. It doesn't have to be grandiose. It doesn't have to be newsworthy. It doesn't have to be what your friends, pastors, rabbis, priests, or colleagues say it should. It just has to be." Dr. Mark Shrime   Dr. Mark G. Shrime is the International Chief Medical Officer at Mercy Ships and a Lecturer in Global Health and Social Medicine at the Harvard Medical School. He is the author of Solving for Why: A Surgeon's Journey to Discover the Transformative Power of Purpose (Hachette 2022).   He previously served as the O'Brien Chair of Global Surgery at the Royal College of Surgeons in Ireland, as the founder and Director of the Center for Global Surgery Evaluation at the Massachusetts Eye and Ear Infirmary, and as Research Director for the Program in Global Surgery and Social Change at Harvard.    He has spoken at the United Nations, WHO, Harvard, Princeton, and around the world addressing issues of healthcare inequity, moral injury in the healthcare workforce, and the non-health outcomes of health policies. In 2018, he was awarded the Arnold P. Gold Humanism in Medicine Award by the American Academy of Otolaryngology—Head and Neck Surgery.   Get Solving for Why here: https://rb.gy/okpa08   Here are some free gifts for you: Overall Approach Used in Well-Managed Strategy Studies free download: www.firmsconsulting.com/OverallApproach   McKinsey & BCG winning resume free download: www.firmsconsulting.com/resumepdf   Enjoying this episode? Get access to sample advanced training episodes here: www.firmsconsulting.com/promo  

Dr. Marc Odrich is Chief Medical Officer at LENZ therapeutics and has decades of experience in private practice, teaching, and medical research that contributes to LENZ Therapeutics success by driving the clinical trial and approval of our novel products. His expertise in authoring and directing over 25 clinical trials throughout his career makes him uniquely qualified to execute the approval process. In addition to his duties as Chief Medical Officer, Dr. Odrich is an Associate Professor of Ophthalmology at the University of Virginia, where he practices and teaches Clinical Ophthalmology specializing in Refractive Surgery and Ocular Surface Disease. He is also the Chief Medical Officer for TearSolutions, Inc., a startup in clinical trials for a new drug developed for dry eye disease. In addition, he is a consultant and member of the Board of Directors for CXLO, Inc., a developer of an innovative treatment for keratoconus and other corneal ectasias, as well as a consultant and medical monitor for Johnson & Johnson's refractive products. Previously, he played pivotal roles in the development and commercialization of the Excimer and Femto lasers as Medical Director at Visx. Dr. Odrich is a graduate of Columbia College and received his medical degree from Columbia University College of Physicians and Surgeons. He completed an internship in internal medicine at Yale's Danbury Hospital before moving to pursue his residency at Columbia's Harkness Eye Institute. Odrich then completed a two-year fellowship focused on cornea and external disease at Harvard's Massachusetts Eye and Ear Infirmary.

Show notes: (1:13) How did she get into the line of work she's in? (2:26) Common issues she sees with her patients (6:17) Good practices, supplements, and exercises (13:44) On blue light-blocking glasses (20:32) UV, sun gazing, and red light (26:24) Finding the right eye health supplement (29:24) Most common eye issue as we age (34:29) Exercises for eye health (36:14) On LASIK eye surgery (38:49) Where to find Dr. Rani Banik (40:26) Outro Who is Dr. Rani Banik?   Dr. Rudrani Banik is a Board-certified Ophthalmologist, fellowship-trained Neuro-Ophthalmologist, and Functional Medicine expert. She is fully trained in ophthalmic surgery and Botox, and she has a special interest in treating Headache and Migraine. Dr. Banik manages a wide spectrum of conditions affecting vision, as well as the complex connections between the eye and brain.   Dr. Banik has specialized training in Functional Medicine. She applies principles of complementary and alternative medicine in conjunction with traditional medical approaches to treat chronic diseases affecting the visual system. She offers a unique approach to managing conditions such as dry eye, macular degeneration, blepharitis, migraine, multiple sclerosis, myasthenia gravis, thyroid eye disease, uveitis, and other autoimmune conditions.   Dr. Banik has thirteen years of training at some of the finest medical and eye institutes in the country. She graduated with a B.A with Honors and M.D. from Brown University. She trained in Internal Medicine at Mount Sinai Medical Center in Miami, followed by Ophthalmology at the University of California, Irvine. She went on to pursue Neuro-Ophthalmology at the Wilmer Eye Institute at Johns Hopkins.   ​She has served on full-time faculty at Albert Einstein College of Medicine, Bronx-Lebanon Hospital Center, and New York Eye and Ear Infirmary of Mount Sinai.   ​Dr. Banik is founder of Envision Health NYC, a private practice based on the Upper East Side in New York City. She is Associate Professor of Ophthalmology at Mount Sinai Icahn School of Medicine. Dr. Banik has won many teaching awards and also serves as principal investigator for 5 multi-centered clinical trials in neuro-ophthalmology. She has authored numerous articles and has presented at national and international meetings. Dr. Banik is a member of the American Academy of Ophthalmology's Exam Development Committee and helps to set the standards for board certification in her field.   ​ Connect with Dr. Rani: Website: https://www.drranibanik.com/ IG: https://www.instagram.com/dr.ranibanik/ YT: https://www.youtube.com/@dr.ranibanik TikTok: https://www.tiktok.com/@dr.ranibanik Links and Resources: Peak Performance Life Peak Performance on Facebook Peak Performance on Instagram    

In this Journal Club episode of T.O.P., The Oculofacial podcast, host Dr. Seanna Grob welcomes three distinguished guests to discuss pivotal research articles from the 2023 November/December issue of OPRs. Dr. Anne Barmettler is an esteemed Associate Professor of Ophthalmology and the Director of the Oculoplastic Service at Albert Einstein College of Medicine in Montefiore Medical Center, New York. She is recognized for her extensive knowledge and specialization in ophthalmic plastic and reconstructive surgery, and she lends her expertise as a member of the editorial board for OPRS. Dr. Grace Lee serves as an Associate Professor of Ophthalmology and an accomplished oculoplastic surgeon at Harvard Medical School and Massachusetts Eye and Ear. Her rich experience and scholarly work are pivotal in the advancement of her field. Dr. Pete Setabutr is a Professor of Ophthalmology and the Director of the Oculoplastic Service at the University of Illinois College of Medicine and Illinois Eye and Ear Infirmary. He is also the Vice Chair of Global Ophthalmology and a valuable contributor to the editorial board for OPRS. The episode delves into potential novel surgical techniques in patients with epiphora and addresses perioperative considerations in overweight and obese patients as well as outcomes of primary monocanalicular stent placement in pediatric patients with Down Syndrome and nasolacrimal duct obstruction. The conversation begins with an intriguing exploration of an alternative to dacryocystorhinostomy, Nasolacrimal Duct Coronary Stent Recanalization (NCR), and its potential to utilize the physiologic anatomy for treating nasolacrimal duct obstructions. Additionally, the episode sheds light on the complexities of managing overweight and obese patients in oculofacial plastic surgery, encompassing perioperative risks and specialized care protocols. The third segment is a retrospective look at the success rates of primary monocanalicular stent placement in pediatric patients with Down Syndrome versus those without, highlighting varied outcomes and the quest for optimal treatments in such clinical scenarios. Key Takeaways: New techniques like Nasolacrimal Duct Coronary Stent Recanalization (NCR) are being investigated as potential alternatives to traditional dacryocystorhinostomy. Managing oculofacial surgery in overweight and obese patients presents unique challenges, including the likelihood of extended operative times and postoperative wound healing difficulties. Pediatric oculoplastic surgery may require bespoke approaches, especially in children with Down Syndrome, where success rates for primary monocanalicular stent placement are significantly lower than in non-Down Syndrome patients. Bicanalicular stent placement with suture tying as a new method to potentially reduce operative room removal is discussed. The conversations in this podcast provide rich, practice-changing insights that could influence oculoplastic surgeons' approach to diverse patient groups. If you're an ASOPRS Member, Surgeon or Trainee and are interesting in hosting a podcast episode, please submit your idea by visiting: asoprs.memberclicks.net/podcast  

Are you experiencing a headache or a migraine? Many women experience migraines throughout their lives, but certain factors that can increase the likelihood of migraines. So what can you do to prevent them?Today, I'm thrilled to have Dr. Rani Banik back on the show. She joined me on episode 204 to discuss the biggest eye issues in women.  In this episode though, we are diving into the world of migraines and why people, especially perimenopausal and menopausal women, may be experiencing them!You will hear:What a migraine is, how it differs from a headache, and if this mattersThe phases of a migraineRisk factors of migraines, both genetic and lifestyleMinimizing your risk of migrainesHow your neurotransmitters interact with your gut healthThe biggest factor that can play a role in if you experience migraines (hint: this is where perimenopause and menopause are key!)And more!More about Dr. Rani:Dr. Rani Banik is a Board-certified Ophthalmologist, fellowship-trained Neuro-Ophthalmologist, and Functional Medicine expert. She is fully trained in ophthalmic surgery and Botox, and she has a special interest in treating Headache and Migraine. Dr. Banik manages a wide spectrum of conditions affecting vision, as well as the complex connections between the eye and brain. She applies principles of complementary and alternative medicine in conjunction with traditional medical approaches to treat chronic diseases affecting the visual system. She offers a unique approach to managing conditions such as dry eye, macular degeneration, blepharitis, migraine, multiple sclerosis, myasthenia gravis, thyroid eye disease, uveitis, and other autoimmune conditions.Dr. Banik has thirteen years of training at some of the finest medical and eye institutes in the country. She graduated with a B.A with Honors and M.D. from Brown University. She trained in Internal Medicine at Mount Sinai Medical Center in Miami, followed by Ophthalmology at the University of California, Irvine. She went on to pursue Neuro-Ophthalmology at the Wilmer Eye Institute at Johns Hopkins. She has served on full-time faculty at Albert Einstein College of Medicine, Bronx-Lebanon Hospital Center, and New York Eye and Ear Infirmary of Mount Sinai. Dr. Banik is founder of Envision Health NYC, a private practice based on the Upper East Side in New York City. She is Associate Professor of Ophthalmology at Mount Sinai Icahn School of Medicine. Dr. Banik has won many teaching awards and also serves as principal investigator for 5 multi-centered clinical trials in neuro-ophthalmology. Connect with Dr. Rani:Dr. Rani's Website: https://www.drranibanik.com/Dr. Rani's Instagram: If you want to lose weight without the risk of gastroparesis, muscle loss, and rebound weight gain, then use MetaboLift instead!Struggling with balancing your hormones? Grab your copy of the The Gutsy Gynecologist's Guide to Balancing your Hormones: https://drtabatha.com/free-guide/Support your hormone balance- EnergyLift! Connect with Dr. Tabatha:Work with us: Schedule a callDr. Tabatha's Facebook: https://www.facebook.com/DrTabathaDr. Tabatha's IG: https://www.instagram.com/thegutsygynecologist/Dr. Tabatha's YouTube: https://www.youtube.com/channel/UCWea1x1abLERehb5yn_nfow

Experiencing dry eyes? Feel like you're constantly straining your eyes? These changes may actually be due to hormone changes or even perimenopause! I know I've started to have eye issues and that it is most likely due to perimenopause!If you've been struggling with your vision, then today's guest, Dr. Rani Banik, is here to explain what is actually causing your eye issues. Together, we dive into the 3 main eye issues women are facing today! You will hear:How vision is affected by age and hormonesConventional ophthalmology vs. Functional ophthalmologyIf carrots are actually good for your eyes How screens may be affecting your visionThe real truth about blue blocker glassesHow annual exam eyes can detect so much more than just changes in visionAnd more!More about Dr. Banik:Dr. Rani Banik is a Board-certified Ophthalmologist, fellowship-trained Neuro-Ophthalmologist, and Functional Medicine expert. She is fully trained in ophthalmic surgery and Botox, and she has a special interest in treating Headache and Migraine. Dr. Banik manages a wide spectrum of conditions affecting vision, as well as the complex connections between the eye and brain. She applies principles of complementary and alternative medicine in conjunction with traditional medical approaches to treat chronic diseases affecting the visual system. She offers a unique approach to managing conditions such as dry eye, macular degeneration, blepharitis, migraine, multiple sclerosis, myasthenia gravis, thyroid eye disease, uveitis, and other autoimmune conditions.Dr. Banik has thirteen years of training at some of the finest medical and eye institutes in the country. She graduated with a B.A with Honors and M.D. from Brown University. She trained in Internal Medicine at Mount Sinai Medical Center in Miami, followed by Ophthalmology at the University of California, Irvine. She went on to pursue Neuro-Ophthalmology at the Wilmer Eye Institute at Johns Hopkins. She has served on full-time faculty at Albert Einstein College of Medicine, Bronx-Lebanon Hospital Center, and New York Eye and Ear Infirmary of Mount Sinai. Dr. Banik is founder of Envision Health NYC, a private practice based on the Upper East Side in New York City. She is Associate Professor of Ophthalmology at Mount Sinai Icahn School of Medicine. Dr. Banik has won many teaching awards and also serves as principal investigator for 5 multi-centered clinical trials in neuro-ophthalmology. Connect with Dr. Rani:Dr. Rani's Website: The book you need to truly transform yourself in 2024 is here! Fast to Faith: A 40-Day Awakening. Reconnect Your Body, Mind, and Soul For Lasting Weight Loss, Sustained Energy, and Unstoppable Strength! AND receive all the awesome BONUSES for being a quick-starter!See ya soon- GOD BLESS YOU!!!Struggling with balancing your hormones? Grab your copy of the The Gutsy Gynecologist's Guide to Balancing your Hormones: https://drtabatha.com/free-guide/Support your hormone balance- EnergyLift! Connect with Dr. Tabatha:Work with us: Schedule a callDr. Tabatha's Facebook: https://www.facebook.com/DrTabathaDr. Tabatha's IG: https://www.instagram.com/thegutsygynecologist/Dr. Tabatha's YouTube: https://www.youtube.com/channel/UCWea1x1abLERehb5yn_nfow

Scientist Leona Zacharias was a rare woman. She graduated from Barnard College in 1927 with a degree in biology, followed by a Ph.D. from Columbia University. But throughout her career she labored behind men with loftier titles who got the bulk of the credit. In the 1940s, when premature babies born with healthy eyes were going blind, Dr. Zacharias was part of the team that worked to root out the cause. In this best of Lost Women of Science episode, host Katie Hafner visits the archives at M.I.T. and The Massachusetts Eye and Ear Infirmary in Boston to try to understand Dr. Zacharias's role in rooting out the cause. For host Katie Hafner, it's personal: Leona Zacharias was her grandmother.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Vance Thompson, MD, Adrienne Graves, PhD, Sean Ianchulev, MD, and Kristen Harmon Igenito, live from AAO Eyecelerator. Welcome to the Eyeluminaries podcast :01 Review of episode 19 1:31 Intro of Vance Thompson, MD 2:13 What is the secret to your success? 3:54 How many fellows have you trained? 5:20 How has having a fellowship training program at Vance Thompson Vision impacted your practice? 6:23 What are the two recently approved products that you are amazed by? 10:02 What is your favorite wine? 12:55 What is your favorite dad joke? 15:25 Intro of Adrienne Graves, PhD 16:59 How does your background help you serve in the companies and non-profits you work with? 19:43 What do strategics do for companies? 24:13 Prescription drug names 25:53 Intro of Sean Ianchulev, MD, MPH 29:45 How do your ideas evolve? 31:53 ·       Who or what inspires you? 45:58 Intro of Kristen Harmon Ingenito 49:39 How is the software different? 51:45 How is market research changing? 55:19 What are you most optimistic about in terms of trends? The most challenging? 57:18 At what point in your life did you decide to work in market research? 59:05 Preview of episode 21 1:02:32 Feedback, questions and guest suggestions at eyeluminaries@healio.com 1:02:40   Adrienne Graves, PhD, serves as an independent director on the boards of Iveric Bio, Nicox S.A., Greenbrook TMS NeuroHealth, Surface Ophthalmics, Qlaris Bio, and TherOptix and serves as director on the Foundation Boards of the American Society of Cataract and Refractive Surgery (ASCRS) Foundation, Glaucoma Research Foundation, American Academy of Ophthalmology Foundation (Emeritus), Retina Global, Himalayan Cataract Project, and the Foundation Fighting Blindness Retinal Degeneration Fund. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Sean Ianchulev, MD, MPH, is a Harvard-trained physician-scientist, a professor of ophthalmology and the head of innovation and technology at New York Eye and Ear Infirmary founder and chairman of Iantrek Inc and Eyenovia and serves as a board member for the American Society of Cataract and Refractive Surgery Foundation and AEYE Health. Kristen Harmon Ingenito has more than a decade of experience in the ophthalmic industry, with nine of those years analyzing data and reporting for Market Scope. Kristen's industry experience began in 2005 at Market Scope, where she served in many roles, including editing, analysis, sales, and marketing. She then joined an ophthalmic patient education software company, where she worked closely with physicians to help drive value in all aspects of their practices, while also training incoming executives on the business of eye care. She returned to Market Scope with added experience to help expand the company's portfolio of products and services. Source: Market Scope Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Vance Thompson, MD, is a board-certified ophthalmologist who specializes in refractive surgery including laser vision correction, implant vision correction and advanced cataract surgery and is the director of refractive surgery at Vance Thompson Vision. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Graves serves as an independent director on the boards of Iveric Bio, Nicox S.A., Greenbrook TMS NeuroHealth, Surface Ophthalmics, Qlaris Bio, and TherOptix and serves as director on the Foundation Boards of the American Society of Cataract and Refractive Surgery (ASCRS) Foundation, Glaucoma Research Foundation, American Academy of Ophthalmology Foundation (Emeritus), Retina Global, Himalayan Cataract Project, and the Foundation Fighting Blindness Retinal Degeneration Fund. Hovanesian consults widely in the ophthalmic field. Ianchulev is the head of innovation and technology at New York Eye and Ear Infirmary founder and chairman of Iantrek Inc and Eyenovia and serves as a board member for the American Society of Cataract and Refractive Surgery Foundation and AEYE Health. Ingenito develops products and provides services to Market Scope. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Thompson is the director of refractive surgery at Vance Thompson Vision.

Are you clear on how to position yourself as a thought leader in your industry on LinkedIn?Have you ever wondered how to stand out on LinkedIn and boost your visibility?How can we optimize our LinkedIn profile strategically for business success?Today, we discuss How to leverage LinkedIn and social media to grow your business online.Watch it on YouTube: https://www.youtube.com/watch?v=J_LiIuN9jG4.LinkedIn, often referred to as the professional networking platform, holds a treasure trove of opportunities for business growth. Beyond its conventional usage, there exist intriguing features and strategies that are bound to transform your online presence. LinkedIn boasts over 774 million users worldwide, making it a colossal hub for networking and business interactions. Interestingly, studies show that profiles with professional headshots receive 14 times more profile views, which underscores the significance of visual appeal on the platform.A common misconception about LinkedIn is that it's solely a platform for job seekers. However, as emphasized by our guest speaker, Dorothy, it's a goldmine for entrepreneurs and businesses aiming to connect and grow. Therefore, we must harness the power of captivating content, clear messaging, and strategic networking so we can unlock a world of opportunities. Remember, it's not just about what you offer, but how you offer it, and who you offer it to.Show Highlights:How to optimize your LinkedIn pageOrganic visibility in LinkedInThe production of powerful content marketing in LinkedInCreating landing pages for email list growthOffer small sales tips by presenting the price mid-pitchOnline course tailored for coaches and consultants on LinkedIn.How to make an impact on your audience. The “What? Why? How?” We need to know to position ourselves as thought leaders in our industry.How to implant BIGVU in content creationAbout our Speaker:Dorothy graduated from Sheffield University with a Masters Degree in Marketing, Advertising and PR. She is passionate about helping entrepreneurs build businesses online. Her expertise is Social Media Strategy and e-mail marketing for businesses in Europe and USA. She also just graduated B-School with Marie Forleo and she will teach you what your business needs and how to grow and position online to create the fundamentals of a healthy long-lasting strategy.Working in the International Financial market in companies like KPMG and Massachusetts Eye and Ear Infirmary plus being a lifelong learner and trained by the world`s leading online business coaches, she owns an arsenal of knowledge and expertise to share with like-minded people who want to work with her and grow their businesses.   Find out more about Dorothy:YouTube: https://www.youtube.com/@lekbello/BIGVU, the powerful Video, Captioning & Teleprompter App:BIGVU 7 days Trial: https://desk.bigvu.tv/register?utm_so...iOS:  https://apps.apple.com/us/app/bigvu-v...Android:  https://play.google.com/store/apps/de...Website:   https://bigvu.tv/-------------------Made Possible by BIGVU - a TV studio pro in your pocket. BIGVU transforms photos, video shoots, and tweets into stunning sequences that captivate your audience.Learn more about BIGVU:Website: https://bigvu.tvTeleprompter: https://bigvu.tv/teleprompter-app.htmlCaptions: https://bigvu.tv/create/auto-captionsGreen Screen: https://bigvu.tv/create/replace-green-screenConnect with us via:https://thevideopresentershow.bigvu.tvhttps://www.instagram.com/bigvu.makerhttps://www.facebook.com/socialvideocreatorhttps://www.linkedin.com/company/bigvuhttps://twitter.com/videoinspire

Vidcast:  https://www.instagram.com/p/CwcMdBzsuYk/ From Boston's Mass. Eye and Ear Infirmary comes the report of an exciting Phase 1 trial using an patient's own eye stem cells to repair a chemically burned cornea.  In this preliminary study of the so-called CALEC procedure which stands for cultivated autologous limbal epithelial cell transplantation, 4 patients with burned corneas each received stem cells from their own cornea limbus following cultivation and amplification of cell numbers in tissue cultures.  The limbus is a stem cell rich zone between the corneal edge and the white sclera that normally produces enough new cells to effect repairs without assistance.  Chemically burned limbal zones do not.  Two of the patients enjoyed sufficient corneal regrowth that they required no further therapy.  The other two had sufficient corneal repair to become candidates for corneal transplants.  Studies are now underway on 15 additional patients as the next step toward offering this option to even more patients….someday soon. https://www.science.org/doi/10.1126/sciadv.adg6470 #cornea #chemicalburns  #cornealtransplantation #limbus #stemcells #ophthalmology

In this episode of the "Future of Technology", we will hear from Dr. Keith N. Darrow, Advisory Board Member at CILcare, in conversation with Yvonne Bendinger-Rothschild, Executive Director of the EACCNY. Their conversation will cover 'Hearing Loss' and the technological advancements that are on the horizon around early detection, preventing cognitive decline and more! Dr. Keith N. Darrow, Advisory Board Member, CILCARE, completed his doctoral work at the joint M.I.T. & Harvard Medical School program in Speech and Hearing Bioscience and Technology. Prior, he completed his clinical audiology degree at Brooklyn College, in New York City. He is a former Clinical Professor at Northeastern University and is currently a tenured professor at Worcester State University. Dr. Darrow's clinical experience is vast and includes a clinical fellowship at the Department of Otolaryngology at Brigham and Women's Hospital and he is co-founder of the Hearing and Brain Centers of America. Dr. Darrow has chosen to lead the Excellence In Audiology. His Amazon.com best-selling books, Stop Living In Isolation, has been read by over 100,000 adults and his newest book, Preventing Decline is a #1 New-Release on Amazon. Dr. Darrow is a nationally recognized speaker, trainer, and researcher and has conducted research at the Massachusetts Eye and Ear Infirmary for over fifteen years. His publications and research have been cited over 1000 times.Yvonne Bendinger-Rothschild, Executive Director of the EACCNY since October 2010. Prior to joining, she has worked and consulted for a number of non-profits and for-profits where she significantly contributed to their growth by raising their public profiles, geographic foot print and relevance within their respective industries. In her roles, she has worked with clients and partners across the US, in Europe, Latin America and Asia.Her priority is to create value for its membership and help grow the organization and its influence on both sides of the Atlantic. To that extend she is spearheading EACC's international expansion strategy and is working with partners across the U.S. and Europe to identify & develop suitable locations and collaborators to expand the EACC chapter network.Thanks for listening! Please be sure to check us out at www.eaccny.com or email membership@eaccny.com to learn more!

About Dr. Caitlin Morrison:Dr. Morrison is the owner of In Focus: Specialty Contact Lens & Vision Solutions, a private practice in Scottsdale, Arizona that specializes in contact lenses for advanced ocular conditions and comprehensive care for difficult visual cases.After graduating from the New England College of Optometry in Boston, Dr. Morrison completed a Cornea & Contact Lens Residency at SUNY College of Optometry in New York City. She is a Fellow of the American Academy of Optometry (FAAO), a Fellow of the Scleral Lens Society (FSLS), and the recipient of both the Bert C. and Lydia M Corwin Contact Lens Award and the Johnson & Johnson Award for Excellence in Contact Lens Patient care.Prior to moving back to her home state of Arizona, Dr. Morrison worked in the cornea department of New York Eye and Ear Infirmary of Mount Sinai in Manhattan specializing in corneal diseases and complications. She is inspired by her patients who have overcome many visual obstacles and are motivated to regain quality vision once again. 

Joan Buckley learns about how to keep your eyes healthy - and what happens when things aren't so clear, pun intended, with Dr. Daniel Laroche, the Director of Glaucoma Services, and President, of Advanced Eyecare of New York. He is affiliated with the New York Eye and Ear Infirmary, and Assistant Professor of Ophthalmology at the Mount Sinai School of Medicine here in New York.

Welcome back to Open globe talk, this is your host, Rizul Naithani and I am joined today with Dr. Jullia A. Rosdahl, an incredible glaucoma specialist and Associate Professor of Ophthalmology at the Duke Eye Center.  Dr. Rosdahl obtained her medical education and PhD from Case Western Reserve University School of Medicine and completed her ophthalmology residency at Massachusetts Eye and Ear Infirmary. She then completed her glaucoma fellowship from the Duke Eye Center. As this recording was conducted in February, we want to acknowledge Black History Month and also celebrate all the women physicians who have furthered the medical field. Please join us in this incredibly important discussion on what it is like to have supportive mentorship and also how we can conduct patient education to be better humans for our patients.

The health of our mouth, teeth and gums and the products you use on them can affect your overall health. Oral health is an essential piece of the puzzle when it comes to health optimization. On today’s episode I holistic dentist, Dr. Reid Winick who is the founder of Dentistry for Health in New York. On this episode you are going to learn how the health of our mouth, teeth and gums and the products we use on them can affect our overall health. Topics Discussed: Should you be brushing with Fluoride toothpaste? Is Fluoride Varnish safe for children? Heavy metal testing Dental Implants Amalgam fillings and whether or not you should remove them The link between oral bacteria and Nitric Oxide levels HPV and oral cancer To visit Dr. Winick's Instagram To visit Dr. Winick's YouTube To visit Dentistry For Health - New York Website Products Discussed: doTERRA On Guard Essential Oil Protective Blend - 15 ml RiseWell Mineral Toothpaste Hydro Floss New Generation Oral Irrigator Bundle with Sulcus Tips HumanN - Nitric Oxide I Indicator Strips Nitric Oxide Dr. Reid L. Winick, D.D.S. is the founder and president of Dentistry for Health New York, a green and sustainable dental practice designed as a haven for overall wellness. Patients throughout the United States seek out Dr. Winick’s whole-body program of Sustainable Dentistry. The personalized treatment programs offered by Dr. Winick treat the patient as a human ecosystem. With the right conditions, the mouth can heal on its own and remain disease free. Dr. Winick’s personalized treatment programs are designed to save teeth without painful gum surgery and extractions. Patients report that Dr. Winick’s sustainable dental wellness programs have virtually eliminated their need for periodontal surgery or dental implants and have improved their overall wellness. Dr. Winick is committed to the environment and to the health and wellness of his patients’ mind, body, and spirit. A graduate of New York University College of Dentistry, Dr. Winick has extensive experience in General Dentistry, as well as the Oral-Systemic Link and in TMJ Dysfunction and Craniofacial Disorders. Dr. Winick is past co-founder and director of the Facial Pain/TMD Clinic at NY Eye & Ear Infirmary. He has completed numerous continuing education courses with an emphasis on Sustainable Dentistry, the Oral-Systemic Link, TMJ Dysfunction & Cervical Dysfunction, Sleep Apnea, Neural Therapy and Biological Dentistry, and Regenerative & Stem Cell Therapies. For questions about today's podcast you can contact Amy Stuttle at podcast@amystuttle.com Click here to learn more about Victory Men's Health This podcast is not medical advice.

The event featured Dr. Ahmad A. Aref, MBA of the Illinois Eye & Ear Infirmary, a board-certified ophthalmologist specializing in glaucoma and cataract surgery. He is an Associate Professor of Ophthalmology and attending physician in the Glaucoma and Cataract Consultation Service at the University of Illinois College of Medicine Department of Ophthalmology and has also authored over 60 scientific publications. The doctor discussed Minimally Invasive Glaucoma Surgeries, also called MIGS. He then explained how MIG procedures differ from other glaucoma surgeries, how MIG procedures are performed, if the operation is permanent, and who might be a viable candidate for the procedure.

Scientist Leona Zacharias was a rare woman. She graduated from Barnard College in 1927 with a degree in biology, followed by a Ph.D. from Columbia University. But throughout her career she labored behind men with loftier titles who got the bulk of the credit. In the 1940s, when premature newborns were going blind after being born with perfectly healthy eyes, Dr. Zacharias was part of the team that worked to root out the cause. In this inaugural episode of Lost Women of Science Shorts, host Katie Hafner visits the archives at M.I.T. and The Massachusetts Eye and Ear Infirmary in Boston to try to understand Dr. Zacharias's role in rooting out the cause.For host Katie Hafner, it's personal: Leona Zacharias was her grandmother.

Scott Brun, MD, began his long career in pharma R&D leadership in the late 1990s, holding key roles at Abbott and AbbVie. Had he picked up a pencil with his right hand, his career may have taken a completely different turn.Dr. Brun earned his medical degree at Johns Hopkins University School of Medicine and completed a residency in ophthalmology at the Massachusetts Eye and Ear Infirmary. A leftie, Dr. Brun ultimately decided not to become ambidextrous. Instead, he joined Abbott as a pharmaceutical physician and began a fruitful career leading development across multiple therapeutic areas.With OIS Podcast host Sophia Pathai, MD, PhD, Dr. Brun looks both forward and ahead, sharing stories from his time at Abbott and AbbVie as well as his insights on promising developments in ophthalmology. At venture capital firm Abingworth, Dr. Brun currently helps young biopharma leaders turn their visions into reality. He's also running his own consulting company and helping Horizon Therapeutics build its internal pipeline.Listen to the podcast today to hear Dr. Pathai and Dr. Brun talk about:Dr. Brun's background, from medicine to industry to consulting and VC work. Pivotal events across therapeutic areas during his tenures at Abbott and AbbVie.  How Dr. Brun fostered teamwork, motivation, and engagement among large teams within large pharmaceutical companies, especially in times of failure. The differences between managing a team of six and leading an organization of 2,000 people across 40-plus countries.The success of Opthea and how it illustrates the need for VCs to think globally. How the current bear market will test early-stage biopharma and biotech, and how these startups can survive current economic challenges. The road ahead. What areas of development look most promising? Gene therapy for dry age-related macular degeneration? Ganglion cell regeneration? Something else?Click “play” to listen.

The event featured Dr. Thasarat Vajaranant, who is an ophthalmic surgeon, physician-scientist, and educator and currently serves as a Professor of Ophthalmology, Vice-Chair for Strategic Initiatives, Director of Glaucoma Service, and Director of the Ai-Ophthalmology Center Data Sourcing and Strategy at the Illinois Eye and Ear Infirmary of the University of Illinois at Chicago. The discussion focused on who is susceptible to getting Glaucoma and possible treatments as well as scheduling regular provider visits with eye-care specialists.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest ophthalmic industry news and interview Sean Ianchulev, MD, MPH. Welcome to the Eyeluminaries podcast :01 A review of the previous episode :23 News and notes with John and Jim 1:31 Alcon to acquire Aerie Pharmaceuticals 1:40 Glaukos, iVeena enter licensing agreement for keratoconus treatment 5:20 Lions Eye Institute to acquire SightLife 8:37 Novaliq submits NDA for CyclASol for treatment of dry eye disease 11:37 AbbVie, iSTAR enter alliance to support MINIject MIGS device 13:30 Introduction of Sean Ianchulev 16:30 The interview 18:37 Impact on Google Glass 21:32 What innovations are you proud of and what projects are you excited about? 26:20 What advice do you have for new entrepreneurs? 33:04 How do you balance your work life and your home life? 36:24 Legends in the field of ophthalmology 38:07 Give feedback at eyeluminaries@healio.com 39:39 A preview of the next episode of Eyeluminaries 39:54 Thanks for listening 40:26 Sean Ianchulev, MD, MPH, is a Harvard-trained physician-scientist, a professor of ophthalmology and the head of innovation and technology at New York Eye and Ear Infirmary founder and chairman of Iantrek Inc and Eyenovia and serves as a board member for the American Society of Cataract and Refractive Surgery Foundation and AEYE Health. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo sits on numerous ophthalmic industry corporate boards and committees after serving in executive roles with Allergan, Avellino Labs, Carl Zeiss and AMO. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. You can find Dr. Ianchulev on LinkedIn: Sean Ianchulev, MD, MPH. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus.

In this episode we are discussing the ear, nose, and throat with Otorhinolaryngologist, Daniel Branovan, M.D.! As the Director and Chair of the New York Ear, Nose & Throat Institute, Dr. Branovan is an Ear, Nose and Throat doctor who has served Brooklyn for 14 years, and who utilizes the most modern technology and equipment to get patients on the road to better health more quickly. He is widely known as a top provider of minimally-invasive sinus surgery. Recently, Dr. Branovan has opened a second medical office in Hallandale Beach, Florida. Dr. Branovan studied medicine at Stanford University and completed his residency at The New York Eye and Ear Infirmary in Otolaryngology. Dr. Branovan also earned a Master's degree at Harvard University. His awards and recognitions include “Best Physicians in America,” New York Magazine's “Best Minimally Invasive Surgeons,” and Castle Connolly's “Best Physicians in the New York Metro Area.” He is certified by the American board of Otolaryngology, and belongs to professional associations like the American College of Surgeons. He is fluent in English and Russian. During our discussion, Dr. Branovan discussed a range of topics including: (1) His training and the pros & cons of being an ENT doctor; (2) a description of a typical day in the office; (2) why we feel pressure in our ears when travelling via airplane; (3) whether certain demographics are predisposed to certain health conditions that an ENT doctor treats; (4) why we shouldn't put Q-tips in our ears and alternatives to cleaning out ear wax; (5) minimally invasive surgery due to advancements in tools and technology ; (5) myths and misconceptions about ENT procedures; (6) how weather, environment, and lifestyle have an impact on your ENT health; and more. We touch on a wide range of topics in this podcast that I know you don't want to miss. Don't forget to listen and share with anyone that you think would be interested in listening as well. Dr. Daniel Branovan can be reached at: Instagram: @doctorbranovan Address: 1000 E. Hallandale Beach Blvd., #1-102, Hallandale Beach, Florida 33009 Phone: 754-400-5959 --- Support this podcast: https://podcasters.spotify.com/pod/show/joneshealthlaw/support

Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are at significant risk for cardiovascular disease and stroke, according to new research from the New York Eye and Ear Infirmary of Mount Sinai. This study, published in the July issue of Retina, is the first to demonstrate a link between the disordersAMD is the leading cause of visual impairment and blindness in people over 65 years old and is the result of damage to the central area of the retina called the macula, which is responsible for reading and driving vision. One major form of early AMD is called drusen, where small yellow cholesterol deposits form in a layer under the retina. They can deprive the retina of blood and oxygen, leading to vision loss. Drusen formation can be slowed by appropriate vitamin supplementation.The other major form of early AMD is the presence of subretinal drusenoid deposits (SDD), which is lesser known and requires high-tech retinal imaging to detect. These deposits are also made of fatty lipids and other materials, but form in a different layer beneath the light-sensitive retina cells, where they are also associated with vision loss. Currently, there is no known treatment for SDD.R Theodore (Ted) Smith MD, Ph.D. is the lead author of this study and joins us in this episode to tell us more. He is a Professor of Ophthalmology and Neuroscience at the Icahn School of Medicine at Mount Sinai (ISMMS) and Director of Biomolecular Retinal Imaging at the New York Eye and Ear Infirmary (NYEEI) of Mount Sinai.

A recent study out of Mount Sinai is the first to demonstrate a link between the disorders.Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are at significant risk for cardiovascular disease and stroke, according to new research from the New York Eye and Ear Infirmary of Mount Sinai. This study, published in the July issue of Retina, is the first to demonstrate a link between the disordersAMD is the leading cause of visual impairment and blindness in people over 65 years old and is the result of damage to the central area of the retina called the macula, which is responsible for reading and driving vision. One major form of early AMD is called drusen, where small yellow cholesterol deposits form in a layer under the retina. They can deprive the retina of blood and oxygen, leading to vision loss. Drusen formation can be slowed by appropriate vitamin supplementation.The other major form of early AMD is the presence of subretinal drusenoid deposits (SDD), which is lesser known and requires high-tech retinal imaging to detect. These deposits are also made of fatty lipids and other materials, but form in a different layer beneath the light-sensitive retina cells, where they are also associated with vision loss. Currently, there is no known treatment for SDD.R Theodore (Ted) Smith MD, Ph.D. is the lead author of this study and joins us in this episode to tell us more. He is a Professor of Ophthalmology and Neuroscience at the Icahn School of Medicine at Mount Sinai (ISMMS) and Director of Biomolecular Retinal Imaging at the New York Eye and Ear Infirmary (NYEEI) of Mount Sinai.

Hello, and welcome to Beauty and the Biz where we talk about the business and marketing side of plastic surgery and how Sheila Barbarino, MD has practices in LA and Austin. I'm your host, Catherine Maley, author of Your Aesthetic Practice – What your patients are saying, as well as consultant to plastic surgeons, to get them more patients and more profits. Now, today's episode is called “Practices in LA and Austin. How? - with Sheila Barbarino, MD". When life throws you a curve ball, you have the choice to duck, run away or figure it out. That's what Sheila Barbarino, MD did. She figured it out. Dr. Barbarino, a cosmetic surgeon of the face and body has a thriving practice in LA with celebrity clientele, lots of PR media opportunities and a great reputation as the go-to source for expert techniques for injectables, laser and aesthetic devices. All was well until she experienced a pull to set up another practice in Austin, TX (you have to listen in to find out).    This week's Beauty and the Biz Podcast is my interview with Dr. Barbarino describing her journey from LA to Austin to worldwide lecturer, innovator and industry thought leader.  It's quite a ride! Visit Dr. Barbarino's Website  

Troy Finn leads campaign and fundraising efforts for the University of New Hampshire across 13 colleges and schools, athletics, centers, and institutes. He joined UNH in 2017 from Development Guild DDI where he provided campaign and fundraising counsel to institutions ranging from large, research-intensive public universities to private liberal arts colleges, schools, and non-profit organizations. Having been a member of fundraising teams during campaigns of historic magnitude at Harvard Chan School of Public Health, Columbia University Medical Center, and Dana-Farber Cancer Institute, Troy has led both front-line philanthropy efforts and back-end development operations. Troy obtained a master's degree in Management and Finance from Harvard University Extension School and a bachelor's degree in philosophy from the College of the Holy Cross. He's the youngest of ten kids and loves exploring the northern New England coast with his husband and their German Shepherds, Candide and Cunegonde.Debbie Dutton has served for the past nine years as the Vice President of Advancement and President of the Foundation at the University of New Hampshire (UNH) where she leads a team of 130 advancement professionals in the leadership phase of capital campaign that follows the University's most ambitious and successful capital campaign to date, Celebrate 150, the Campaign for UNH. During this effort, UNH has surpassed all previous records in fundraising and engagement and just closed the campaign June 2018 at $308M well above the $275M goal. Prior to this role, she served as vice president for development and alumni relations at Colby College. During her six-year tenure at Colby, and before being promoted to vice president, she served as campaign director and led the school's largest fundraising effort, the Reaching the World campaign, which surpassed its goal to raise $376 million when it concluded in 2010.Debbie's career in development began at the Maine chapter of the National Multiple Sclerosis Society. She has held development positions in major gifts and senior management at three Harvard teaching hospitals: the Massachusetts Eye and Ear Infirmary, Children's Hospital, and the Joslin Diabetes Center. She also was a senior leadership giving officer at Bates College.Debbie earned a Bachelor of Arts degree in journalism from the University of Maine and a Master of Science degree in business management from Lesley College. She lives in Kennebunk, Maine with her husband and their two children.

Dr. Maura Cosetti is an experienced audiologist with clinical specializations in adult and pediatric hearing disorders. She is the Director of the Ear Institute of New York Eye and Ear Infirmary at Mount Sinai, which is one of the most advanced hearing centers in the United States. She is also the Director of their Cochlear Implant Program, both an academic and clinical program for patients of all ages.  Along with these titles, Dr. Cosetti has performed invaluable research on hearing loss through the use of virtual reality. She leads the Otology-Neurotology Fellowship Program at Mount Sinai and Co-chairs the William House Cochlear Implant Study Group. In this episode… The broader field of audiology can be incredibly diverse with multiple facets of research. One facet that is often overlooked is the relationship between balance and hearing loss. We all know that our balance is calibrated with inner-ear fluid, but the intricacies and relationships are still being heavily researched. There's one new tool, however, that might surprise you.  Dr. Maura Cosetti and her research staff at Mount Sinai have been looking into vestibular problems and analyzing partial deafness. Among their instruments is virtual reality, which allows them to look at sensory integration in a new way. Their facility is among the most advanced in the United States, and now they open up about their research and their unusual methods. Dr. Mark Syms talks with Dr. Maura Cosetti, the Director of the Ear Institute of New York Eye and Ear Infirmary at Mount Sinai, about her research on vestibular problems and their use of virtual reality. They discuss the finer details of vestibular problems and how it relates to balance. They then go through discussions on subcategorization of hearing loss, what qualifies as normal hearing, and neurocognitive function. Check it all out on this episode of the ListenUp! Podcast!

"The only thing worse than being blind, is having sight but no vision." Helen Keller "Glaucoma is called the silent thief of sight...because when you have elevated eye pressure, and it's damaging your eyes, you don't feel it. It can make you lose 90 to 100% of your vision before you notice it." Dr. Daniel La Roche While Helen Keller speaks to the vision with which we approach growing older, in today's conversation we focus on loss of sight vision. It is critical to prevent those vision disorders that become an increasing worry as we personally age, or as we take care of others who are losing their sight. A 2020 survey of blindness in people aged 50 years and older found that globally the second most common cause of blindness was glaucoma, affecting 3.6 million people. Today I talk with glaucoma specialist, Dr. Daniel Laroche, Director of Glaucoma Services and president of Advanced Eye Care of New York. He is a clinical assistant professor of ophthalmology with the Icahn School of Medicine at Mount Sinai Medical Center. Dr. LaRoche received his bachelor's degree from New York University, and his medical doctorate with honors in research, from Weill Cornell University Medical College, he completed his medical internship at Montefiore Hospital, his ophthalmology residency at Howard University Hospital in Washington DC and his glaucoma fellowship at the New York Eye and Ear Infirmary with Glaucoma Associates of New York, specializing in the diagnosis and treatment of glaucoma We discuss types of glaucoma, the prevalence in different ethnic groups, and the importance of annual eye checkups to recognize, prevent or treat the major causes of blindness. Cataracts, glaucoma, age-related macular degeneration and diabetic retinopathy affected 21 million people > 51 globally in this 2020 survey (https://doi.org/10.1016/S2214-109X(20)30489-7) As well as your annual eye test, lifestyle habits, exercise, good nutrition, sleep and meditation are important in preserving eye health.  We also discussed the powerful daily supplement I take to protect my eyes, especially the vulnerable macula area. Schedule a call with me at the link below to learn more about how you can protect your eyes. Contact Dr. Daniel LaRoche www.advancedeyecareny.com https://www.facebook.com/Advanced-Eyecare-of-New-York Contact  Dr. Gillian Lockitch Email: askdrgill@gmail.com - I love your feedbackSchedule a complimentary Living Younger Discovery Call  at https://bit.ly/3LbWvSV Order your copy of Growing Older Living Younger: The Science of Aging Gracefully and the Art of Retiring Comfortably at www.gillianlockitch.com

On this episode of the UnsCripted podcast, Rachel and Alex sit down with Dr. Lisa Kelly to discuss how to handle patient or colleague-generated microaggressions. Dr. Kelly is a board certified ophthalmologist at the University of Cincinnati Medical Center. She completed her medical school at Harvard Medical School, ophthalmology residency at Stanford University, received a Masters of Education from Johns Hopkins School of Education, and completed a fellowship in corneal transplantation at Harvard University's Massachusetts Eye and Ear Infirmary. She is also  the director of Advancing Inclusion in Medical Education at the University of Cincinnati College of medicine, serves as course director for the Physician and Society 201 and 202 courses, and is the director of medical student education in ophthalmology.Join us as we dive into the definition and origin of the term "microaggression", describe how these develop in the workplace and the clinic, and identify the deleterious effects that these aggressions have on women and URM (e.g. exacerbating imposter syndrome). Dr. Kelly also describes the discrete, subtle forms that these aggressions take (micro-assaults, micro-insults, and micro-invalidations), and provides key insight and advice as to how victims can navigate these aggressions in effective and constructive ways. Show Notes:Definition of microaggressions by Psychologist Derald Sue, PhD - "The everyday slights, indignities, put downs and insults that people of color, women, LGBT populations or those who are marginalized experiences in their day-to-day interactions with people."

This podcast is about big ideas on how technology is making life better for people with vision loss. Today's big idea is: How will remote diagnostic tests change ophthalmology and vision care? It might be a foreign concept for some, but the specialists in today's episode, Dr. Peter Pham and Dr. Sean Ianchulev, founders of (Keep Your Sight, a nonprofit focused on remote diagnostic vision tests) share how they can conduct more reliable perimetry tests that help detect macular degeneration, glaucoma, and other conditions that lead to vision loss and eventually blindness —  remotely, while patients stay home. Developments like these in remote diagnostics are a stepping stone for the ways machine learning will impact the field of ophthalmology in the future. This episode also features Dr. Einar Stefansson and Dr. Arna Gudmundsdottir, developers of the app, Retina Risk, which helps with remote risk assessment of diabetic eye disease for people with diabetes, as well as Sherrill Jones, who lost her vision due to glaucoma.   The Big Takeaways: Retina Risk was created to help people with diabetes assess in real-time their individualized risk for sight-threatening diabetic retinopathy. The app was created back in 2009 and the concept of using technology and algorithms to calculate risk was still quite foreign to most people. What goes into taking a regular perimetry test today? Patients have to come into the office, wait, register, wait some more, get taken to a dark room to be positioned correctly, and after 20-30 minutes, you get a result. Now, there's an easier way: patients can take these tests at home. Why is telescreening so important? Dr. Pham and Dr. Ianchulev noticed it could take months for patients to be scheduled in for routine visual field tests. By that time, the glaucoma may have advanced, and in some cases, rapidly. There was an unmet need here and there was a better way to serve people quicker and more efficiently, especially people from rural communities who did not have readily available access to healthcare. Medicare did not allow for doctors to reimburse their services unless it was conducted within the physician's office. This led to a lot of roadblocks in telemedicine, despite the technology being available for the last 15-plus years. Thankfully, in December of 2020, policies were changed so that doctors would be reimbursed for remote patient monitoring.   Tweetables: “We know that our blindspot is 15 degrees away from fixation and, with simple trigonometry, you can now use that blindspot to help position patients correctly in front of the computer monitor. We can now use online technology to perform visual field tests.” — Dr. Peter Pham “It was our goal to do a hardware-free digital/virtual device. We felt in ophthalmology, we're kind of lucky. We are looking at a visual function. So perimetry lends itself to a fully virtual software as a service device.” — Dr. Sean Ianchulev “I think technology will help us get to the next level. Technology has been around for this, but it hasn't been applied for this.” — Dr. Sean Ianchulev   Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss.   Pertinent Links: Lighthouse Guild Retina Risk Keep Your Sight.org   Guest Bios: Dr. Peter Pham & Dr. Sean Ianchulev are both the Co-Founders of Keep Your Sight. Dr. Pham is a boarded certified ophthalmologist who has devoted his professional life to restoring sight and helping patients keep their vision. As a surgeon and clinician, Dr. Pham treats conditions such as glaucoma, cataract, and macular degeneration, all of which can cause blindness. As a researcher, he worked on the development of a novel delivery system for introducing large-sized molecular compounds into thousands of living cells simultaneously. Realizing the importance of technology and innovation for screening and prevention, Dr. Pham teamed up with Dr. Ianchulev to develop the KYS telemedicine system for vision health. Dr. Ianchulev has been on the cutting edge of innovation, making an impact in the treatment of major eye diseases such as macular degeneration and glaucoma. He was instrumental in the development of many new therapies and advances, such as Lucentis for AMD and Diabetic Retinopathy, intraoperative aberrometry for high-precision cataract surgery, micro-stent technology for glaucoma, the miLOOP interventional technology for cataract surgery, and others. Dr. Einar Stefansson & Dr. Arna Gudmundsdottir are both the Co-Founders of Retina Risk. Dr. Stefansson is a leader in the field of diabetic eye disease and diabetic screening and head supervisor for product development and clinical science. Dr. Stefansson graduated from the University of Iceland Medical School in 1978 with honors. He received a PhD degree in physiology from Duke University in 1981 followed by a residency at Duke. Dr. Gudmundsdottir takes an active role in all product development and clinical testing. Her expertise gives valuable insight into practical usage of products and medical approaches. Dr. Gudmundsdottir graduated from the University of Iceland Medical School in '92. She undertook a fellowship program in endocrinology at the University of Iowa Hospital and Clinics. Sherrill Jones lives in New York City and volunteers administrative services in Lighthouse Guild's Volunteer Services department.   Host Bio: Dr. Calvin W. Roberts Calvin W. Roberts, MD, is President and Chief Executive Officer of Lighthouse Guild, the leading organization dedicated to providing exceptional services that inspire people who are visually impaired to attain their goals. Dr. Roberts has a unique blend of academic, clinical, business, and hands-on product development experience. Dr. Roberts is a Clinical Professor of Ophthalmology at Weill Cornell Medical College. He was formerly Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies where he coordinated global development and research efforts across their vision care, pharmaceutical, and surgical business units. As a practicing ophthalmologist from 1982 to 2008, he performed more than 10,000 cataract surgeries as well as 5,000 refractive and other corneal surgeries. He is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics, and innovative treatment regimens. He also holds patents on the wide-field specular microscope and has done extensive research on ophthalmic non-steroidals and postoperative cystoid macular edema. Dr. Roberts has co-founded a specialty pharmaceutical company and is a frequent industry lecturer and author. He currently serves as an Independent Director on multiple corporate boards and has served as a consultant to Allergan, Johnson & Johnson, and Novartis. A graduate of Princeton University and the College of Physicians and Surgeons of Columbia University, Dr. Roberts completed his internship and ophthalmology residency at New York-Presbyterian Hospital/Columbia University Medical Center in New York. He also completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston.

This podcast is about big ideas on how technology is making life better for people with vision loss. Today's big idea centers on the place where big ideas get born — the human brain. In today's episode, Dr. Roberts and his guests explore theories of brain plasticity, sensory substitution, and sensory augmentation. Dr. Patricia Grant discusses the BrainPort, which uses sensory substitution in this case, the nerve fibers in the tongue, to send information to the brain instead of the optic nerve. Dr. John-Ross Rizzo is developing a device to be called the Sensory Halo, which is supported by sensory augmentation. Both guests share what is being learned about sensory substitution and augmentation through these technologies and how this understanding will help perfect future devices to enable people with vision impairment to see better.   The Big Takeaways: The BrainPort is a headset device with a camera that picks up visual input as the eyes would. It uses the theory of sensory substitution by sending stimulation to the nerve fibers on the tongue. The device picks up visual formation in grayscale imagery: lighter areas of the images produce high stimulation on the tongue, while dark areas produce none. This contrast allows users to identify objects in their environment. The BrainPort device is meant for people who are blind so it's not crowding out a person's residual vision. And surprisingly, both users who are congenitally blind and users who have seen before and have a visual memory — have performed the same in clinical trials.  This shows that users are not experiencing a memory of sight. They are learning to interpret the camera's image through stimulating the nerve fibers on their tongue. In the future, there are opportunities for collaboration between BrainPort and other technologies to continue to enhance the user experience to create more autonomy. Another device being developed that draws on some aspects of sensory augmentation is the Sensory Halo. Using a device with sensory augmentation is more intuitive to use than a device that uses sensory substitution. The Sensory Halo is designed to empower the wearer by delivering key pieces of information to safely and independently navigate their environment.   Tweetables: “We put the brain port on him and started training him, and we were doing some mobility tasks...And I was walking around the room and he would just scan the room. Then all of a sudden, I could feel when he perceived me.” — Dr. Patricia Grant “The great thing about the BrainPort is that it gives a person their own sense. It's something that they can experience on their own, and that is of great value to a person who is blind.” — Dr. Patricia Grant “Simply put, I just want to amplify your existing senses and augment what I can give to you right now so that you can have a richer experience.” — Dr. John-Ross Rizzo   Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss.   Pertinent Links: Lighthouse Guild BrainPort Assistive Technology & Advanced Wearables by John-Ross Rizzo, MD, MSCI   Guest Bios: Patricia Grant, PhD, Director of Clinical Research, Wicab, Inc. Dr. Grant joined Wicab, Inc. as Director of Clinical Research in February 2014. She previously served as Co-Investigator for Wicab's FDA clinical trial and currently serves as the Principal Investigator of a clinical trial, funded by the US Department of Defense, investigating the safety and efficacy of the BrainPort for people who have been blinded by traumatic injury. Her future research goals include demonstrating the value of the BrainPort in the workplace, in addition to teaching spatial concepts to children. Prior to joining Wicab, Dr. Grant was the Director of Research at the Chicago Lighthouse for People Who Are Blind and Visually Impaired and a Research Specialist in the Low Vision Research and the Applied Physics laboratories in the Department of Ophthalmology & Visual Sciences at the University of Illinois at Chicago. In addition to her work at Wicab, Dr. Grant has contributed to research in the areas of methods for assessing loss of vision due to retinal disease, treatments to optimize remaining vision, the psychological effects of vision loss, and the measurement of retinal image quality and ocular aberration. She earned a BA in Psychology, an MS in Public Health Sciences, and PhD from the School of Public Health at the University of Illinois at Chicago, with a concentration in behavioral science and eye health promotion.   John-Ross (JR) Rizzo, MD, MSCI, Director of Innovation and Technology, Assistant Professor Department of Rehabilitation Medicine and Department of Neurology, NYU Langone Medical Center John-Ross (JR) Rizzo, MD, MSCI, is a physician-scientist at NYU Langone Medical Center. He is serving as the Director of Innovation and Technology for the Department of Physical medicine and rehabilitation at Rusk Institute of Rehabilitation Medicine, with cross-appointments in the Department of Neurology and the Departments of Biomedical & Mechanical and Aerospace Engineering New York University Tandon School of Engineering. He is also the Associate Director of Healthcare for the NYU Wireless Laboratory in the Department of Electrical and Computer Engineering at New York University Tandon School of Engineering. He leads the Visuomotor Integration Laboratory (VMIL), where his team focuses on eye-hand coordination, as it relates to acquired brain injury, and the REACTIV Laboratory (Rehabilitation Engineering Alliance and Center Transforming Low Vision), where his team focuses on advanced wearables for the sensory deprived and benefits from his own personal experiences with vision loss. He is also the Founder and Chief Medical Advisor of Tactile Navigation Tools, LLC, where he and his team work to disrupt the assistive technology space for those with visual impairments of all kinds, enhancing human capabilities. He partners with a number of industrial sponsors and laboratories throughout the country to help breakthrough new barriers in disability research and/or motor control.   Host Bio: Dr. Calvin W. Roberts Calvin W. Roberts, MD, is President and Chief Executive Officer of Lighthouse Guild, the leading organization dedicated to providing exceptional services that inspire people who are visually impaired to attain their goals. Dr. Roberts has a unique blend of academic, clinical, business, and hands-on product development experience. Dr. Roberts is a Clinical Professor of Ophthalmology at Weill Cornell Medical College. He was formerly Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies where he coordinated global development and research efforts across their vision care, pharmaceutical, and surgical business units. As a practicing ophthalmologist from 1982 to 2008, he performed more than 10,000 cataract surgeries as well as 5,000 refractive and other corneal surgeries. He is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics, and innovative treatment regimens. He also holds patents on the wide-field specular microscope and has done extensive research on ophthalmic non-steroidals and postoperative cystoid macular edema. Dr. Roberts has co-founded a specialty pharmaceutical company and is a frequent industry lecturer and author. He currently serves as an Independent Director on multiple corporate boards and has served as a consultant to Allergan, Johnson & Johnson, and Novartis. A graduate of Princeton University and the College of Physicians and Surgeons of Columbia University, Dr. Roberts completed his internship and ophthalmology residency at New York-Presbyterian Hospital/Columbia University Medical Center in New York. He also completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston.

This podcast is about big ideas on how technology is making life better for people with vision loss. This episode's big idea is navigation and how to implement a navigation solution that enables people with vision impairment to broadly travel cities — how and when they want to, independently. Dr. Roberts talks with Javier Pita, the creator of such a technology called NaviLens, which marries location finding with information.  Dr. Roberts also talks with representatives of New York City's Metropolitan Transit Authority — one of the biggest transportation hubs in the world. They discuss the importance of accessible public transportation for people who are visually impaired and how NaviLens technology can help make independent navigation a reality.    The Big Takeaways: NaviLens system uses improved QR technology with a new type of code made up of four colors that enables it to store more information than a black and white QR code.  Using a smartphone, the NaviLens app scans the area. Once it picks up the unique NaviLens  code, the app provides the embedded information audibly to the user along with their distance/directionality from the code.  As long as the code appears anywhere in the field of view of the smartphone camera, the code is detected and information is delivered.  NaviLens is more accurate than GPS technology because it takes into account smaller distances that are crucial to navigation for people who are visually impaired. NaviLens codes can be read up to 12 times farther away than QR or bar codes as well as at 160-degree angle. Future advances to the NaviLens technology include a 360-degree technology that will register and retain the user's location so the system can still tell where they are, and guide them to the destination even if they lose contact with the code. In addition, the NaviLens GO app uses advanced technology to help users navigate indoor spaces such as stores and to locate items in the store.   This technology is elegant, inexpensive, flexible, easy to use, and fits seamlessly into a user's life. While already part of public transportation in Barcelona, cities like New York City are testing it and hope to make this technology a more integral part of their public transportation system.   Tweetables “Public transportation is the answer to so much inequity across all urban areas, and nonurban areas. If we can work to make the system as safe as possible for any range of abilities, that would be an enormous win, and huge piece making public transit truly public transit.” – Mira Philipson, Systemwide Accessibility Analyst, Metropolitan Transportation Authority New York City Transit “I could walk down the hallway and it's telling me when I've arrived at this department and the door is right in front of me — it really gives me that autonomy that I really crave.” - Ed Plumacher, Adaptive Technology Specialist, Lighthouse Guild “We began in public transportation because for us and the users on our team, it is super important to make public transportation more accessible.” - Javier Pita, Founder and CEO NaviLens “Accessibility needs to be built into products, websites, software, whatever it is, from the ground up, because it will just lead to a better product overall.”  Gian Carlo Pedulla, Supervisor, NYC Department of Education and Member, Advisory Committee for Transit Accessibility, Metropolitan Transportation Authority New York City Transit   Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss.   Pertinent Links: Lighthouse Guild NaviLens NaviLens GO   Guest Bios: Javier Pita Lozano, Founder and CEO, NaviLens Javier is the CEO of NaviLens, a solution whose objective is to increase autonomy, social inclusion and quality of life of the visually impaired. Any place can adopt the NaviLens technology in an easy way to improve the space's accessibility through the use of a new patented cutting-edge technology artificial markers called ddTags. Entrepreneur with more than 15 years of experience in launching disruptive technologic companies. Javier and his team are working hard to make this world more accessible for the visually impaired people.  Mira Philipson, Analyst, Systemwide Accessibility, Office ofthe President, Metropolitan Transportation Authority New York City Transit Gian Carlo Pedulla, Supervisor, NYC Department of Education and Member, Advisory Committee for Transit Accessibility, Metropolitan Transportation Authority New York City Transit Gian Carlo Pedulla was born and raised in Bensonhurst, Brooklyn. Legally blind due to Leber's Congenital Amaurosis, he has persevered to overcome his blindness as well as all related obstacles to meet both personal and professional goals. Raised in an Italian American home, he learned the importance of a good meal, being fastidious, having a strong work ethic, and to be as independent as possible despite his blindness. After 15 years of teaching, Mr. Pedulla is now an administrator for Educational Vision Services within the New York City Department of Education. Besides his passion for Mathematics, Physics, and being a Teacher of the Visually Impaired, Mr. Pedulla enjoys music and has been successful as a professional Disk Jockey performing at numerous private and corporate functions throughout the tri-state area over the last 25 years. Mr. Pedulla has been able to adapt and integrate himself to the different school environments and to utilize his strong interpersonal skills to interact with a variety of individuals and personalities, disabled and non-disabled alike. Assistive Technology has been an integral part of his ability to access an array of materials and complete a variety of assignments to achieve goals, both in academia and the workplace. Edward Plumacher, Adaptive Technology Specialist, Lighthouse Guild Adaptive Technology Specialist for Lighthouse Guild since 2016 Founder of a tech company that created products and services for domestic and international professional sports leagues and their television broadcast rights holders, providing advanced optical imaging systems for quantifying and measuring live action recreated in real-time 3-D computer generated video replays. Also produced scoring and measurement systems for teams, coaches, managers and league governing bodies. His world changed when he lost his vision — including his career — though it still involved technology. Purchased first iPhone after first orientation and mobility training. Self-taught how to use voiceover over a weekend, and went from having difficulty trying to email on his computer with a magnifying glass and mouse to texting for the first time, easily accessing email calendars, and the internet. Was very active with the Foundation Fighting Blindness (FFB) and became President of the Long Island chapter.  Began making presentations on smartphones and smart tablets for FFB just after he lost his sight. Created audio tutorials, ran workshops and networking groups on adaptive technology. Puts together curriculums on teaching people with vision loss about using technology. Worked with New York State Commission for the Blind (NYSCB) to develop a curriculum for providing services on iOS devices and became one of the first people in NY State authorized to conduct iPhone and iPad training. Experienced in podcasting and media, facilitates a peer-to-peer support group at NY Public Library's Andrew Heiskell Library, and is also very active in sports such as running, skiing, beat baseball, tandem cycling and outrigger canoeing.    Host Bio: Dr. Calvin W. Roberts Calvin W. Roberts, MD, is President and Chief Executive Officer of Lighthouse Guild, the leading organization dedicated to providing exceptional services that inspire people who are visually impaired to attain their goals. Dr. Roberts has a unique blend of academic, clinical, business, and hands-on product development experience. Dr. Roberts is a Clinical Professor of Ophthalmology at Weill Cornell Medical College. He was formerly Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies where he coordinated global development and research efforts across their vision care, pharmaceutical, and surgical business units. As a practicing ophthalmologist from 1982 to 2008, he performed more than 10,000 cataract surgeries as well as 5,000 refractive and other corneal surgeries. He is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics, and innovative treatment regimens. He also holds patents on the wide-field specular microscope and has done extensive research on ophthalmic non-steroidals and postoperative cystoid macular edema. Dr. Roberts has co-founded a specialty pharmaceutical company and is a frequent industry lecturer and author. He currently serves as an Independent Director on multiple corporate boards and has served as a consultant to Allergan, Johnson & Johnson, and Novartis. A graduate of Princeton University and the College of Physicians and Surgeons of Columbia University, Dr. Roberts completed his internship and ophthalmology residency at New York-Presbyterian Hospital/Columbia University Medical Center in New York. He also completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston.

This podcast is about big ideas on how technology is making life better for people with vision loss. Today's big idea highlights how innovations don't happen in a vacuum, but rather a long chain of science and research and developments that build on each other. Dr. Shelley Fried's work exemplifies this process. It took him a career's worth of experiments and adjustments to enable his cortical brain implants to bypass the eye and restore the patient's ability to perceive light. He had a lot of obstacles to overcome, everything from circumventing the brain's natural inflammatory response to getting the research published. One thing is clear, breakthroughs take time and you cannot give up in the process. Your work often becomes an iteration of an iteration. Dr. Fried took inspiration from the artificial retina, which was prototyped from a cochlear implant. Dr. Fried's revolutionary technology is another step towards a world in which no person is limited by their visual capacity.   The Big Takeaways: A cochlear implant is a neuroprosthetic device surgically implanted in the cochlea, the inner part of the ear that is responsible for the transmission of nerve impulses in to the auditory cortex of the brain. Originally developed in 1950, the modern form was honed in the 1970s with help from NASA engineer. Dr. Mark Humanyan took design cues from the cochlear when he was developing the Argus II retinal implant.  What is a retinal prosthesis and how does it work? The simplest way to explain it is that it's an array of electrodes that stimulates the retina and it helps restore vision loss. They work for some blindness cases but not all. For example, this treatment is not recommended for people with advanced glaucoma. Dr. Fried took inspiration from retinal prostheses to build upon the cortical brain implant. The implants are revolutionary because it means they go directly to the source (the brain). The cortical brain implant works by gathering information externally and it converts that data to stimulate the brain so the patient can perceive it. However, vision science doesn't end there! Vision science keeps building on itself. In this case, the cortical implant technology was inspired by artificial retinas, which took their inspiration from the cochlear implant. How do you target a single neuron? Dr. Fried's innovative solution was the use of coils, which are smaller than a human hair, to help specify which neurons need activation. When you go directly to the brain, there are some complications that occur. The brain sees the implant as a threat and creates an inflammatory response, which blocks the electrodes from communicating with one another. By using these coils, it bypasses the body's natural inflammatory response and keeps the lines of communication open. This innovation in technology did not happen overnight. It took over a year and a half to get the coil experiments to work alone, and that doesn't include all the other methods Dr. Fried experimented with that didn't succeed. Science is about building upon prior research, and it takes time and a lot of experimentation before a solution will work.   Tweetables: “Cochlear implants had taught us that if you even put some of a rudimentary signal in the ear, that the brain can start to use it….. So we want of reconfigured a cochlear implant and used it to stimulate the retina”.  — Dr. Mark Humayun “In its simplest form, a retina prosthesis is an array of electrodes. The common one is 6x10 electrodes and each electrode is designed to stimulate a small portion of the retina.” — Dr. Shelley Fried “We run into additional problems when we go into the brain that don't exist in the retina. One of them is the brain has a huge inflammatory response to the implant.” — Dr. Shelley Fried   “Coils are not only more stable over time, but they're more selective.  They're able to create a smaller region of activation. And so we think we can get much higher acuity with coils than we can with conventional electrodes.” – Dr. Shelley Fried “Our advance was that we showed that we could really shrink down coils to the sub millimeter size and that they would still be effective, that they can still induce neural activation. – Dr. Shelley Fried “I was fortunate that I certainly was not one of the pioneers in terms of being one of the first people to be implanted. [B]eing able to rely on other people's experiences and being able to trust the process was really helpful.” – Rebecca Alexander, cochlear implant recipient   Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss.   Pertinent Links: Lighthouse Guild Rebalexander.com Dr. Shelley Fried   Guest Bios: Dr. Shelley Fried Shelley I. Fried, PhD, is an Associate Professor of Neurosurgery, Harvard Medical School and an Associate Professor for Massachusetts General Hospital, Department of Neurosurgery. He is the developer of cortical brain implants. Dr. Fried was inspired to do this work after reading a New York Times article on the in-depth work that went behind trying to restore vision to returning blind Vietnam vets.   Dr. Mark Humayun Mark S. Humayun, MD, PhD, is Director, USC Ginsburg Institute for Biomedical Therapeutics and Co-Director, USC Roski Eye Institute. Dr. Humayun has devoted much of his career to clinical and scientific research in ophthalmology and bioengineering, becoming both a biomedical engineer and professor of ophthalmology. You can hear more about him and his work in Episode 4 — The Development of Artificial Vision.   Rebecca Alexander Rebecca Alexander is an author, psychotherapist, group fitness instructor, advocate, and extreme athlete who is almost completely blind and deaf. Born and raised in the San Francisco Bay Area, she currently lives in New York City.   Host Bio: Dr. Calvin W. Roberts Calvin W. Roberts, MD, is President and Chief Executive Officer of Lighthouse Guild, the leading organization dedicated to providing exceptional services that inspire people who are visually impaired to attain their goals. Dr. Roberts has a unique blend of academic, clinical, business, and hands-on product development experience. Dr. Roberts is a Clinical Professor of Ophthalmology at Weill Cornell Medical College. He was formerly Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies where he coordinated global development and research efforts across their vision care, pharmaceutical, and surgical business units. As a practicing ophthalmologist from 1982 to 2008, he performed more than 10,000 cataract surgeries as well as 5,000 refractive and other corneal surgeries. He is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics, and innovative treatment regimens. He also holds patents on the wide-field specular microscope and has done extensive research on ophthalmic non-steroidals and postoperative cystoid macular edema. Dr. Roberts has co-founded a specialty pharmaceutical company and is a frequent industry lecturer and author. He currently serves as an Independent Director on multiple corporate boards and has served as a consultant to Allergan, Johnson & Johnson, and Novartis. A graduate of Princeton University and the College of Physicians and Surgeons of Columbia University, Dr. Roberts completed his internship and ophthalmology residency at New York-Presbyterian Hospital/Columbia University Medical Center in New York. He also completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston.

About Dr. Caity Morrison: Dr. Morrison is the owner of In Focus: Specialty Contact Lens & Vision Solutions, a private practice in Scottsdale, Arizona that specializes in contact lenses for advanced ocular conditions and comprehensive care for difficult visual cases. After graduating from the New England College of Optometry in Boston, Dr. Morrison completed a Cornea & Contact Lens Residency at SUNY College of Optometry in New York City. She is a Fellow of the American Academy of Optometry (FAAO), a Fellow of the Scleral Lens Society (FSLS), and the recipient of both the Bert C. and Lydia M Corwin Contact Lens Award and the Johnson & Johnson Award for Excellence in Contact Lens Patient care. Prior to moving back to her home state of Arizona, Dr. Morrison worked in the cornea department of New York Eye and Ear Infirmary of Mount Sinai in Manhattan specializing in corneal diseases and complications. She is inspired by her patients who have overcome many visual obstacles and are motivated to regain quality vision once again.   

This podcast is about big ideas on how technology is making life better for people with vision loss. Today's big idea is the power of virtual reality - how people are using VR to remap sight and help people with vision loss in their daily lives Dr. Roberts visits with Grace Andruszkiewicz and Dr. Frank Werblin about how emerging technologies help people with low vision access the areas of vision they still have, by using a virtual reality system. They also talk about how sight works biologically, and how one such device, IrisVision, works to connect people socially.  The Big Takeaways: Virtual reality changes the sensory inputs our brain receives, to change the visual field our eyes are scanning and the sounds we are hearing. These new inputs trick the brain into thinking we're in a different reality.  IrisVision is a combination of a Samsung phone and a headset for virtual reality that modulates the visual field of a person with low vision so they can see better. The technology re-maps the visual world they're seeing so it becomes resonant with their individual pathology. The development of IrisVision technology started as a device to improve macular degeneration, but has evolved to resolve any type of visual pathology (retinal versus cortical), including magnification or “minification” (reducing the size) to modify the visual field depending on the user's visual function.  IrisVision re-mapping provides the brain access to the raw material; after using the device for a few months, users' native vision is often improved, ultimately leading to a renewed social connection for users.  People who use the device need to have some remaining vision.   Tweetables: “What's really meaningful too is helping people go back to places that are really emotionally meaningful from their past. When they feel like they're back in that place or doing that thing, they come alive again.” - Grace Andruszkiewicz describing senior's experience with virtual reality “Because the screen is a half an inch from your eyes, it's not uncommon for people to see something clearly for the first time in a VR headset.” - Grace Andruszkiewicz “It occurred to me that what was needed was a low-cost, non-invasive device that could recode the visual message in a way that would resonate with those islands of sight that people still have remaining.” - Dr. Frank Werblin on the development of IrisVision “Assisting patients with visual loss has a much broader function - it reconnects people with each other. IrisVision assists people in seeing the visual world, but what it's really doing is reconnecting them socially.” - Dr. Frank Werblin Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss. Pertinent Links: Lighthouse Guild Rendever IrisVision Guest Bios: Dr. Frank Werblin, Co-Founder, Chief Scientist, IrisVision IrisVision was founded by Dr. Frank Werblin, an MIT graduate, Guggenheim Fellow, and professor at UC Berkeley. Dr. Werblin is renowned for his scientific contributions to our understanding of retinal functioning. He has dedicated his life to innovating, developing and delivering an affordable non-invasive solution for millions of people with low vision. With the help of our research partners at Stanford, Johns Hopkins, UC Berkeley, UPMC, The Chicago Lighthouse for the Blind, and other institutions contributing to low vision science, IrisVision is the realization of that lifetime of work. He is dedicated to pushing the boundaries of low vision solutions by continuing to expand the relationship with top vision scientists and technology powerhouses like Samsung. Grace Andruszkiewicz, Director of Marketing & Partnerships, Rendever Host Bio Dr. Calvin W. Roberts Calvin W. Roberts, M.D., is President and Chief Executive Officer of Lighthouse Guild, the leading organization dedicated to addressing and preventing vision loss. Dr. Roberts has a unique blend of academic, clinical, business, and hands-on product development experience. Dr. Roberts is a Clinical Professor of Ophthalmology at Weill Cornell Medical College. He was formerly Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies where he coordinated global development and research efforts across their vision care, pharmaceutical and surgical business units. As a practicing ophthalmologist from 1982 to 2008, he performed more than 10,000 cataract surgeries as well as 5,000 refractive and other corneal surgeries. He is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics, and innovative treatment regimens. He also holds patents on the wide-field specular microscope and has done extensive research on ophthalmic non-steroidals and postoperative cystoid macular edema. Dr. Roberts has co-founded a specialty pharmaceutical company and is a frequent industry lecturer and author. He currently serves as an Independent Director on multiple corporate boards and has served as a consultant to Allergan, Johnson & Johnson, and Novartis. A graduate of Princeton University and the College of Physicians and Surgeons of Columbia University, Dr. Roberts completed his internship and ophthalmology residency at New York-Presbyterian Hospital/Columbia University Medical Center in New York. He also completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston.

This podcast is about big ideas on how technology is making life better for people with vision loss. Today's big idea is all about the cutting edge advancements in ocular bionic prosthetics. The Argus II is a device that uses a camera and a chip to stimulate the retina and send signals to the brain. Our guest, Dr. Mark Humayun, developer of the Argus II, speaks with Dr. Roberts about the development of this device, and the importance of the collaboration between developers and early adopters. He talks about the engineering, neurophysiology, and surgical challenges they've overcome to get to where they are, as well as what kind of advancements might be possible in the future.   The Big Takeaways: The Argus II is a device with two components: a wearable component that consists of glasses with a camera and video processing unit and an implanted device that includes an antenna and an electronic chip that sends electrodes to stimulate the remaining cells of the retina. The visual system is similar to a computer in that it requires hardware (our eyes, retina, optic nerve, visual cortex) and software (converts signals to what we describe as sight). When developing artificial vision, Dr. Humayun had to pinpoint how much of the retina needed to be replaced, as well as how much of the retina needed to still exist for the device to work. The electronic system stimulates groups of neurons into visual perceptions. Users of the Argus II can currently perceive up to 10 shades of gray. Dr. Humayun and his team are working on getting the device to generate color vision by stimulating the retina at different frequencies, which the wearer learns to associate with a named color. The cochlear implant was a big influence on the initial development of Argus II — they reconfigured a cochlear implant and used it to stimulate the retina rather than the cochlea. As they reconfigure and continue to develop the device, the collaboration between actual users and developers is crucial. Now that they have the hardware and technology, they can focus on future developments like an implant that bypasses the optic nerve and sends electrodes directly to the visual cortex.   Tweetables: “I've been so lucky my whole adult life to have that collaborative experience with everyone who's ever built legs for me.” — Aimee Mullins, actor, athlete, public speaker, and double amputee “The most emotional thing for me was being able to see letters again. That was such an emotional experience, I don't know how to put it into words.” — Barbara Campbell, Argus II implant recipient “You can think of it like this, that it wirelessly connects the blind person to a camera, and jumpstarts the otherwise blind eye and sends the information to the brain.” — Dr. Mark Humayun “There are some features that are different than our human eye, there are some advantages, but clearly our human eye is incredibly, exquisitely engineered to give you a very pristine, refined, and high-resolution image.” — Dr. Mark Humayun   Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss.   Pertinent Links: Lighthouse Guild Argus II   Guest Bio: Dr. Mark Humayun Mark S. Humayun, MD, PhD, is Director, USC Ginsburg Institute for Biomedical Therapeutics and Co-Director, USC Roski Eye Institute. Dr. Humayan received his Bachelor of Science degree from Georgetown University in 1984, his Master's Doctorate from Duke University in 1989, and his PhD from the University of North Carolina, Chapel Hill in 1994. He completed his ophthalmology residency at Duke Eye Center and fellowships in both vitreoretinal and retinovascular surgery at Johns Hopkins Hospital. He stayed on as faculty at Johns Hopkins where he rose to the rank of associate professor before moving to USC in 2001. Dr. Humayun has devoted much of his career to clinical and scientific research in ophthalmology and bioengineering, becoming both a biomedical engineer and professor of ophthalmology. Dr. Humayun led a talented and diverse team of interdisciplinary researchers with the ultimate goal of creating the world's first artificial retina. He assembled a team of world experts with a wide range of proficiency, including biomedical engineering, computer science, medicine, chemistry, biology, and business. In clinical trials since 2007 and approved by the FDA in 2013, the Argus II retinal implant, represents the culmination of a visual restoration strategy that offers an unprecedented degree of sight to those with complete retinal blindness. He was elected to the prestigious National Academy of Medicine (NAM) and National Academy of Engineering (NAE) for his pioneering work to restore sight. With over 200 publications and more than 100 patents and patent applications, Dr. Humayun has received several research awards, which include the 2005 Innovator of the Year award. He was also featured as one of the top 10 inventors in Time Magazine in 2013, voted as one of the Best Doctors in America for three years, and one of the top 1% of Doctors by U.S. News & World Report. In 2016, Dr. Humayun received the National Medal of Technology and Innovation from President Barack Obama for his innovative work and development of the Argus II. Host Bio: Dr. Calvin W. Roberts Calvin W. Roberts, MD, is President and Chief Executive Officer of Lighthouse Guild, the leading organization dedicated to providing exceptional services that inspire people who are visually impaired to attain their goals. Dr. Roberts has a unique blend of academic, clinical, business, and hands-on product development experience. Dr. Roberts is a Clinical Professor of Ophthalmology at Weill Cornell Medical College. He was formerly Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies where he coordinated global development and research efforts across their vision care, pharmaceutical, and surgical business units. As a practicing ophthalmologist from 1982 to 2008, he performed more than 10,000 cataract surgeries as well as 5,000 refractive and other corneal surgeries. He is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics, and innovative treatment regimens. He also holds patents on the wide-field specular microscope and has done extensive research on ophthalmic non-steroidals and postoperative cystoid macular edema. Dr. Roberts has co-founded a specialty pharmaceutical company and is a frequent industry lecturer and author. He currently serves as an Independent Director on multiple corporate boards and has served as a consultant to Allergan, Johnson & Johnson, and Novartis. A graduate of Princeton University and the College of Physicians and Surgeons of Columbia University, Dr. Roberts completed his internship and ophthalmology residency at New York-Presbyterian Hospital/Columbia University Medical Center in New York. He also completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston.

This podcast is about big ideas on how technology is making life better for people with vision loss. Today's big idea is how the technology used in instruments that extend human vision to space is being relied on by vision technology developers in devices that help people with vision loss in everyday tasks here on Earth. Using substitute senses has allowed scientists across many fields to continue their work without the use of sight. The eSight is one such device that stimulates the remaining functioning vision to improve the quality of life for users. Dr. Roberts speaks with Charles Lim about the development of the device, the principles behind how it works, and the motivation for future improvements.   The Big Takeaways: Astronomers and other scientists who are blind can continue to make meaningful contributions to their field by using substitute senses — even discovering things unseen to the human eye — especially in fields where instruments do most of the heavy lifting. eSight is designed to help people with low vision; they've found that with the right stimuli, they can leverage the dormant portions of the eye that still have some function. It is a wearable and mobile device that maximizes the visual information provided to the brain to naturally compensate for gaps in the user's vision. As they continue to develop the device, some of the most important factors are making sure it's comfortable, accessible for a wide range of wearers, has a long battery life, and is future-proof. The ability to possibly change individual lives, and to create a more accessible world, is one of the most motivating reasons behind this technology advancement and continues to drive the developments that are on the horizon for eSight.   Tweetables: “What it all means is how do we leverage the technology advances in cameras, image, sensors, and processing to allow...our users to enhance their vision through more information.” - Charles Lim, Chief Technology Officer, eSight “What we did is that we converted into sound data from a gamma-ray burst. We were able to listen to small variations in the data that were not visible to the human eye.” — Dr. Wanda Diaz Merced, Astronomer “Astronomers have realized that you can learn a lot about the Universe by developing instruments that can be extensions of our own senses.” — Dr. Bernard Beck-Winchatz, Astrophysicist “I dream of a future where eSight can really become a natural extension of our users' vision.” — Dr. Charles Lim   Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss.   Pertinent Links: Lighthouse Guild Touch the Universe, Noreen Grice eSight   Guest Bios: Charles Lim, Chief Technology Officer, eSight Charles Lim is a global technology expert with 20 years of experience and a proven record of scaling businesses. Previously, Charles worked in progressive global senior leadership positions with IMAX where he led strategy, operations and business development during a key moment in the company's rapid growth stage.  He's also acted as a consultant with MaRS Discovery District where he worked closely with technology startups to ensure their success and was a key player in building the MaRS technology innovation ecosystem. Charles has successfully led engineering teams developing leading-edge fiber optic broadcast systems, consumer electronics and aerospace technologies that earned him multiple awards including the NASA Goddard Space Flight Center Award of Excellence. Charles holds a Bachelor of Electrical Engineering and Master of Electrical and Computer Engineering from Ryerson University, and an MBA from Rotman School of Management at the University of Toronto. He has also completed executive-level courses at Harvard Business School. Dr. Bernard Beck-Winchatz, Professor, DePaul University Interim Director of STEM Center, Professor of Physics & Astrophysics, Graduate Program Director of Physics & Astrophysics; Campus Director of Illinois Space Grant Consortium Wanda Díaz-Merced Wanda Díaz-Merced is an astronomer best known for using sonification to turn large data sets into audible sound. She currently works at the South African observatory's Office of Astronomy for Development (OAD) leading the project AstroSense. As someone who has lost their eyesight, she is a leader in increasing equality of access to astronomy and using audible sound to study astrophysical data. Wanda has been included in the list of the 7 most trailblazing women in science by the BBC.   Host Bio: Dr. Calvin W. Roberts Calvin W. Roberts, MD, is President and Chief Executive Officer of Lighthouse Guild, the leading organization dedicated to providing exceptional services that inspire people who are visually impaired to attain their goals. Dr. Roberts has a unique blend of academic, clinical, business, and hands-on product development experience. Dr. Roberts is a Clinical Professor of Ophthalmology at Weill Cornell Medical College. He was formerly Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies where he coordinated global development and research efforts across their vision care, pharmaceutical, and surgical business units. As a practicing ophthalmologist from 1982 to 2008, he performed more than 10,000 cataract surgeries as well as 5,000 refractive and other corneal surgeries. He is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics, and innovative treatment regimens. He also holds patents on the wide-field specular microscope and has done extensive research on ophthalmic non-steroidals and postoperative cystoid macular edema. Dr. Roberts has co-founded a specialty pharmaceutical company and is a frequent industry lecturer and author. He currently serves as an Independent Director on multiple corporate boards and has served as a consultant to Allergan, Johnson & Johnson, and Novartis. A graduate of Princeton University and the College of Physicians and Surgeons of Columbia University, Dr. Roberts completed his internship and ophthalmology residency at New York-Presbyterian Hospital/Columbia University Medical Center in New York. He also completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston.

This podcast is about big ideas on how technology is making life better for people with vision loss. Today's big idea is about using augmented reality, machine learning, and soon, fifth generation (5G) connectivity to improve vision. The Eyedaptic Eye2 is software-driven smart glasses for people with vision impairment. Dr. Roberts speaks with Dr. Mitul Mehta and Jay Cormier about how Eyedaptic uses machine learning to develop algorithms to guide augmentations that adapt to a person's vision deficits, habits and environments to help them see better. They also discuss how 5G connectivity is going to continue to enhance the user experience for Eyedaptic users.   The Big Takeaways: Eyedaptic identifies a wearer's visual defect, and adapts to that specific problem by using technology to address the gaps in vision. It applies that technology to commercial augmented reality headsets. Algorithms analyze what the camera in the user's Eyedaptic glasses is looking at, as well as what the user is doing at the time, and the combination informs what the user sees. As augmented reality continues to develop, the next big breakthrough is going to be connectivity using 5G. This will enable the Eyedaptic glasses to transfer large amounts of data very quickly, improving future machine learning algorithms; it will also allow the device to become more mobile.   Tweetables: “That brought me to the whole concept of being able to use technology to fix problems with the body. One of the things I found ... was people trying to solve the problem of vision loss not medically, but with technology.” — Dr. Mitul Mehta “When we were able to put our technology on one of our users, this fellow couldn't read anymore and we were able to get him to read again. Certainly, that was our first indication that this technology can really do what we hoped it could do.” — Jay Cormier “In essence, what these algorithms are doing is to become adaptive not only to the person's vision deficits but also their habits and environments.” — Jay Cormier “The goal of any sort of vision technology company, in the end, should also be trying to help people who have ‘normal' vision, be able to see things that they cannot currently see.” — Dr. Mitul Mehta “Ophthalmology is the most exciting field of medicine because ophthalmologists in general are very pro-technology and they're always trying to get better.” - Dr. Mitul Mehta   Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss.   Pertinent Links: Lighthouse Guild Eyedaptic   Guest Bios: Jay Cormier, President and CEO, Eyedaptic As an experienced technology executive and entrepreneur, Jay has a strong track record of founding, growing, and turning around businesses. He has completed several successful exits totaling over $750M, across embedded software, SaaS, and hardware solutions. By leveraging his background at Analog Devices, Jay has led marketing, sales, engineering, operations, strategic partnerships, business development, new product strategy and execution. As Vice President & General Manager, Jay achieved exits at Teridian, Sierra Monolithics and Mindspeed using his expertise building high performance, execution-oriented multi-disciplinary teams. Jay earned his BS in Electrical Engineering from Worcester Polytechnic Institute and an MBA from Northeastern University. Dr. Mitul Mehta, Medial Advisor, Eyedaptic Mitul is a board-certified ophthalmologist with fellowship training in medical and surgical diseases of the retina at UCI's Gavin Herbert Eye Institute. He earned his Medical Degree from the Keck School of Medicine of USC, and also holds a M.S. in BioPhysics from Georgetown and B.S. from MIT, where he first ventured into software startups. He completed fellowship training in vitreoretinal surgery at the New York Eye & Ear, and conducts research on surgical devices and techniques, as well as on vitreoretinal diseases, such as diabetic retinopathy and macular degeneration. Mitul is the cofounder of the online America Retina Forum and the Young Retina Forum as well as the editor of the retina section for the surgical education website, CSurgeries.com.   Host Bio: Dr. Calvin W. Roberts Calvin W. Roberts, MD, is President and Chief Executive Officer of Lighthouse Guild, the leading organization dedicated to providing exceptional services that inspire people who are visually impaired to attain their goals. Dr. Roberts has a unique blend of academic, clinical, business, and hands-on product development experience. Dr. Roberts is a Clinical Professor of Ophthalmology at Weill Cornell Medical College. He was formerly Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies where he coordinated global development and research efforts across their vision care, pharmaceutical, and surgical business units. As a practicing ophthalmologist from 1982 to 2008, he performed more than 10,000 cataract surgeries as well as 5,000 refractive and other corneal surgeries. He is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics, and innovative treatment regimens. He also holds patents on the wide-field specular microscope and has done extensive research on ophthalmic non-steroidals and postoperative cystoid macular edema. Dr. Roberts has co-founded a specialty pharmaceutical company and is a frequent industry lecturer and author. He currently serves as an Independent Director on multiple corporate boards and has served as a consultant to Allergan, Johnson & Johnson, and Novartis. A graduate of Princeton University and the College of Physicians and Surgeons of Columbia University, Dr. Roberts completed his internship and ophthalmology residency at New York-Presbyterian Hospital/Columbia University Medical Center in New York. He also completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston.

This podcast is about big ideas on how technology is making life better for people with vision loss. Today's big idea is how we can use touch and sound together to create spatial awareness. Just like learning to play the piano or another instrument, smart cane technology engages the both sound and touch to compensate for loss of vision. Kürşat Ceylan, the founder and CEO of WeWALK, shares how the WeWALK smart cane engages a number of senses to develop new autonomy for users, and how their technology is a jumping-off point for integrating other technologies. The Big Takeaways: People who are blind use their canes to detect obstacles in front of them to understand and visualize their surroundings. Tapping the cane allows them to hear the echo as well; hearing and touch go hand in hand. WeWALK is a white cane enabled with smart technologies: it detects obstacles at the head level, pairs with a smartphone so both don't need to be held, and has the flexibility to receive new features with the software updates. This particular smart cane is a gateway for many different useful technologies that are adapted for accessibility for people who are vision impaired. New technologies for people who are blind tap into and expand on our natural senses. WeWALK uses ultrasound for obstacle detection, which converts the data from the ultrasound waves into meaningful information for the user — through touch (vibration) and eventually sound (a beep). The big vision for the future of WeWALK is to turn it into a personal hub assistant, including image recognition, voice assistant, and smart-stick integration. A more robust smart cane will allow for a fully autonomous journey for people who are visually impaired or blind. Tweetables: “The research has shown that people who take piano lessons or instrumental lessons, their spatial skill is more established than the people who have never done it.” — Yu-Pin Hsu “From when I started [playing piano] to now, I hear differently, and I think maybe I hear other things differently. I don't know if my sound is better, or my brain is more attuned to listening and absorbing other sounds.” — Bill Graham “It's easy to rely on the sight, but as a visually impaired person, I can't rely on my sight. It means I have room to rely on my other sense.” — Kürşat Ceylan “WeWALK is powerful because of our partnerships. It gives the opportunity to integrate smart solutions into smart canes as well.” — Kürşat Ceylan Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss. Pertinent Links: Lighthouse Guild WeWALK Guest Bios: Kürşat Ceylan Kürşat Ceylan was born in 1986. He was born blind. Kürşat studied psychological counseling at Boğaziçi University. During his university years, he was selected to attend the YGA Leadership Program as one of 50 participants out of 50,000 applicants. He volunteered on projects for the socioeconomic development of the visually impaired. After his graduation, he started to work at Roche, Istanbul. During this time, he was producing and hosting a Turkish award-winning radio show called, "Exploration of Emotions that are Suppressed by Sight", which aired every week on NTV Radio. In 2015, he resigned from Roche and started working at YGA as project leader, spearheading projects for the visually impaired. Kürşat won various global awards for his work in the field of visual impairment, dealing with indoor navigation, audio description in movie theatres, and the WeWALK Smart Cane. Currently, Kürşat Ceylan is the co-founder of WeWALK Technology INC, which strives to solve problems for people who are visually impaired through innovation. Yu-Pin Hsu, EdD, OT, SCLV is  Manager, Vision Rehabilitation Projects for Lighthouse Guild and a Classically Trained Pianist Host Bio: Dr. Calvin W. Roberts Calvin W. Roberts, MD, is President and Chief Executive Officer of Lighthouse Guild, the leading organization dedicated to addressing and preventing vision loss. Dr. Roberts has a unique blend of academic, clinical, business, and hands-on product development experience. Dr. Roberts is a Clinical Professor of Ophthalmology at Weill Cornell Medical College. He was formerly Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies where he coordinated global development and research efforts across their vision care, pharmaceutical, and surgical business units. As a practicing ophthalmologist from 1982 to 2008, he performed more than 10,000 cataract surgeries as well as 5,000 refractive and other corneal surgeries. He is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics, and innovative treatment regimens. He also holds patents on the wide-field specular microscope and has done extensive research on ophthalmic non-steroidals and postoperative cystoid macular edema. Dr. Roberts has co-founded a specialty pharmaceutical company and is a frequent industry lecturer and author. He currently serves as an Independent Director on multiple corporate boards and has served as a consultant to Allergan, Johnson & Johnson, and Novartis. A graduate of Princeton University and the College of Physicians and Surgeons of Columbia University, Dr. Roberts completed his internship and ophthalmology residency at New York-Presbyterian Hospital/Columbia University Medical Center in New York. He also completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston.

This podcast is about big ideas on how technology is making life better for people with vision loss. Today's big idea is seeing with your ears — exploring technology that uses audio to connect people with vision loss to the world around them. Dr. Cal Roberts speaks with Dr. Yonatan Wexler about the OrCam My Eye device. They explore the ideas of whether the brain can recreate a picture using audio alone, how well hearing can replace lost sight, and what are the discovery processes for using audio description technology as a substitute for vision. The Big Takeaways: Developments in technology allow for the use of audio as a substitute for vision for people with no or low vision, sending signals to the brain to create a picture in their mind's eye. The natural gesture of pointing signals the OrCam device to enable audio feedback to the wearer, the same way our selective vision helps us discriminate objects from our surroundings. The journey to the development of this device was intricate and involved, highlighting the constant evolution of this technology and future opportunities for development such as the ability for a user to save their experiences. Tweetables: “I have an idea of how the ball field is shaped, where the players are standing, and what they do. … It's not a fully-fleshed out picture, but it … helps me know what everyone is doing at any … moment.” — Karen, a blind baseball fan describing hearing a game play-by-play “A radio allows you to use your imagination. In some ways, radio is even better.” — John Sterling “It happens and you describe it and hopefully you describe it well. I hope it helps the listeners see the game.” — John Sterling, Voice of the New York Yankees “The beauty of the brain is that it can generate sight using the information from the ears.” — Dr. Wexler   Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss. Pertinent Links: Lighthouse Guild OrCam Guest Bios: John Sterling John Sterling is an American sportscaster best known as the radio play-by-play announcer of Major League Baseball's New York Yankees. Sterling called 5060 consecutive Yankees games, beginning in 1989, before taking an 8-day (4-game) break in July 2019. Dr. Yonaton Wexler Dr. Yonatan Wexler is an experienced researcher in the field of Artificial Intelligence and Computer Vision. He has conducted research at the Hebrew University, University of Maryland, Oxford University, Weizmann Institute of Science, and Microsoft. His passion is efficient use of visual information that enables exciting new abilities. He is the recipient of the Marr Prize, the highest in the field of Computer Vision. Currently, Yonatan leads the R&D at OrCam, a company that pioneers a generation of clever AI-based assistants that improve people's daily lives. The OrCam MyEye revolutionizes the lives of the blind and the visually impaired. It clips onto any pair of glasses and verbalizes information they find hard to perceive. The OrCam Focus breaks new grounds for hearing aids. It solves the age-old “cocktail party problem” for the first time and lets the wearer focus on one speaker, discarding any other chatter and noise, hence solving the #1 problem with existing solutions. Host Bio Dr. Calvin W. Roberts Calvin W. Roberts, M.D., is President and Chief Executive Officer of Lighthouse Guild, the leading organization dedicated to addressing and preventing vision loss. Dr. Roberts has a unique blend of academic, clinical, business, and hands-on product development experience. Dr. Roberts is a Clinical Professor of Ophthalmology at Weill Cornell Medical College. He was formerly Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies where he coordinated global development and research efforts across their vision care, pharmaceutical and surgical business units. As a practicing ophthalmologist from 1982 to 2008, he performed more than 10,000 cataract surgeries as well as 5,000 refractive and other corneal surgeries. He is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics, and innovative treatment regimens. He also holds patents on the wide-field specular microscope and has done extensive research on ophthalmic non-steroidals and postoperative cystoid macular edema. Dr. Roberts has co-founded a specialty pharmaceutical company and is a frequent industry lecturer and author. He currently serves as an Independent Director on multiple corporate boards and has served as a consultant to Allergan, Johnson & Johnson, and Novartis. A graduate of Princeton University and the College of Physicians and Surgeons of Columbia University, Dr. Roberts completed his internship and ophthalmology residency at New York-Presbyterian Hospital/Columbia University Medical Center in New York. He also completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston.